<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Dev Biol</journal-id><journal-id journal-id-type="iso-abbrev">J Dev Biol</journal-id><journal-id journal-id-type="publisher-id">jdb</journal-id><journal-title-group><journal-title>Journal of Developmental Biology</journal-title></journal-title-group><issn pub-type="epub">2221-3759</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407686</article-id><article-id pub-id-type="pmc">PMC12101424</article-id>
<article-id pub-id-type="doi">10.3390/jdb13020017</article-id><article-id pub-id-type="publisher-id">jdb-13-00017</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">In Vitro</italic> Embryo Culture Impacts Heart Mitochondria in Male Adolescent Sheep</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6960-7703</contrib-id><name><surname>Amanollahi</surname><given-names>Reza</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Holman</surname><given-names>Stacey L.</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2806-6274</contrib-id><name><surname>Meakin</surname><given-names>Ashley S.</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Padhee</surname><given-names>Monalisa</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Botting-Lawford</surname><given-names>Kimberley J.</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Song</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>MacLaughlin</surname><given-names>Severence M.</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Kleemann</surname><given-names>David O.</given-names></name><xref rid="af2-jdb-13-00017" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Walker</surname><given-names>Simon K.</given-names></name><xref rid="af2-jdb-13-00017" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3975-215X</contrib-id><name><surname>Kelly</surname><given-names>Jennifer M.</given-names></name><xref rid="af2-jdb-13-00017" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Rudiger</surname><given-names>Skye R.</given-names></name><xref rid="af2-jdb-13-00017" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>McMillen</surname><given-names>I. Caroline</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Wiese</surname><given-names>Michael D.</given-names></name><xref rid="af3-jdb-13-00017" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3594-1455</contrib-id><name><surname>Lock</surname><given-names>Mitchell C.</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref><xref rid="c1-jdb-13-00017" ref-type="corresp">*</xref><xref rid="fn1-jdb-13-00017" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8602-8519</contrib-id><name><surname>Morrison</surname><given-names>Janna L.</given-names></name><xref rid="af1-jdb-13-00017" ref-type="aff">1</xref><xref rid="c1-jdb-13-00017" ref-type="corresp">*</xref><xref rid="fn1-jdb-13-00017" ref-type="author-notes">&#x02020;</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Michiue</surname><given-names>Tatsuo</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jdb-13-00017"><label>1</label>Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia; <email>reza.amanollahi@mymail.unisa.edu.au</email> (R.A.); <email>stacey.holman@unisa.edu.au</email> (S.L.H.); <email>ashley.meakin@unisa.edu.au</email> (A.S.M.); <email>monalisa@bindi-international.org</email> (M.P.); <email>k.botting@ucl.ac.uk</email> (K.J.B.-L.); <email>song.zhang@thekids.org.au</email> (S.Z.); <email>severence.maclaughlin@gmail.com</email> (S.M.M.); <email>icmcmillen@outlook.com</email> (I.C.M.)</aff><aff id="af2-jdb-13-00017"><label>2</label>South Australian Research and Development Institute, Turretfield Research Centre, Rosedale, SA 5350, Australia; <email>dave.kleemann@sa.gov.au</email> (D.O.K.); <email>walkersa@adam.com.au</email> (S.K.W.); <email>jenkelly@internode.on.net</email> (J.M.K.); <email>skye.rudiger@sa.gov.au</email> (S.R.R.)</aff><aff id="af3-jdb-13-00017"><label>3</label>Centre for Pharmaceutical Innovation, Clinical &#x00026; Health Sciences University of South Australia, Adelaide, SA 5001, Australia; <email>michael.wiese@unisa.edu.au</email></aff><author-notes><corresp id="c1-jdb-13-00017"><label>*</label>Correspondence: <email>mitchell.lock@unisa.edu.au</email> (M.C.L.); <email>janna.morrison@unisa.edu.au</email> (J.L.M.); Tel.: +61-8830-20200 (M.C.L.); +61-8-8302-2166 (J.L.M.)</corresp><fn id="fn1-jdb-13-00017"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>17</elocation-id><history><date date-type="received"><day>12</day><month>2</month><year>2025</year></date><date date-type="rev-recd"><day>17</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>09</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Assisted reproductive technology (ART)such as <italic toggle="yes">in vitro</italic> embryo culture (IVC), is widely used in human infertility treatments; however, its long-term effects on the cardiac health of offspring remain unclear. This study aimed to determine whether the effects of IVC on cardiac metabolism and associated signaling pathways persist after birth into adolescence. Embryos were either transferred to an intermediate ewe (ET) or cultured <italic toggle="yes">in vitro</italic> in the absence (IVC) or presence of human serum (IVCHS) with methionine supplementation (IVCHS+M) for 6 days after mating. Naturally mated (NM) ewes were used as controls. Protein expression and hormone concentrations in the left ventricle (LV) were analyzed using Western blot and LC-MS/MS analyses, respectively. IVC was associated with sex-specific alterations in cardiac mitochondria, with males exhibiting reduced mitochondrial abundance. Cardiac protein expression of oxidative phosphorylation (OXPHOS) complexes 1 and 4 was reduced by IVC. Additionally, IVC reduced protein expression of PDK-4 and Mn-SOD in the IVCHS+M group, which may impact energy efficiency and defense against oxidative stress. These changes may predispose IVC offspring to cardiac oxidative stress and mitochondrial dysfunction, particularly in males. This study provides insights into the sex-dependent effects of IVC on cardiac health, emphasizing the importance of evaluating long-term cardiovascular risks associated with IVC protocols.</p></abstract><kwd-group><kwd>ART</kwd><kwd><italic toggle="yes">in vitro</italic> embryo culture</kwd><kwd>cardiac metabolism</kwd><kwd>male</kwd><kwd>heart</kwd><kwd>mitochondria</kwd><kwd>adolescent sheep</kwd></kwd-group><funding-group><award-group><funding-source>Australian Research Council Future Fellowship</funding-source><award-id>FT170100431</award-id></award-group><award-group><funding-source>National Health and Medical Research Council</funding-source><award-id>511340</award-id></award-group><award-group><funding-source>University of South Australia President&#x02019;s Scholarship</funding-source></award-group><funding-statement>J.L.M. and the molecular work were funded by an Australian Research Council Future Fellowship (Level 3; FT170100431). The animal work was funded by a National Health and Medical Research Council Project Grant (511340 to ICM and JLM). R.A. was funded by a University of South Australia President&#x02019;s Scholarship.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-jdb-13-00017"><title>1. Introduction</title><p>In recent decades, the use of <italic toggle="yes">in vitro</italic> fertilization (IVF) and related procedures involving the handling of eggs or <italic toggle="yes">in vitro</italic> embryo culture (IVC), has increased rapidly in both human and livestock reproduction [<xref rid="B1-jdb-13-00017" ref-type="bibr">1</xref>,<xref rid="B2-jdb-13-00017" ref-type="bibr">2</xref>]. The first human IVC birth occurred in 1978, and many such offspring have now reached adulthood [<xref rid="B3-jdb-13-00017" ref-type="bibr">3</xref>]. However, there is contrasting evidence that offspring conceived through IVC may have an increased risk of heart disease, highlighting that alterations in the periconceptional environment can have significant effects on postnatal health [<xref rid="B4-jdb-13-00017" ref-type="bibr">4</xref>,<xref rid="B5-jdb-13-00017" ref-type="bibr">5</xref>,<xref rid="B6-jdb-13-00017" ref-type="bibr">6</xref>,<xref rid="B7-jdb-13-00017" ref-type="bibr">7</xref>]. To closely mimic the in vivo environment, human serum was used in IVC in the 1980s [<xref rid="B6-jdb-13-00017" ref-type="bibr">6</xref>,<xref rid="B8-jdb-13-00017" ref-type="bibr">8</xref>]. Subsequent ruminant studies revealed various developmental abnormalities, including increased heart weight in fetuses exposed to IVC with serum [<xref rid="B9-jdb-13-00017" ref-type="bibr">9</xref>,<xref rid="B10-jdb-13-00017" ref-type="bibr">10</xref>,<xref rid="B11-jdb-13-00017" ref-type="bibr">11</xref>]. This effect was likely due to reduced methylation, suggesting that supplementing the culture media with methionine may help restore methylation and normalize cardiac growth [<xref rid="B9-jdb-13-00017" ref-type="bibr">9</xref>]. However, serum-free media have now become the gold standard for optimal preimplantation embryo culture in all species, but there remains a cohort of individuals exposed to human serum during the periconceptional period that is now reaching early adulthood [<xref rid="B12-jdb-13-00017" ref-type="bibr">12</xref>,<xref rid="B13-jdb-13-00017" ref-type="bibr">13</xref>].</p><p>The developmental origins of health and disease (DOHaD) concept suggests that environmental factors during embryo culture may exert additional risk factors for poor adult health outcomes [<xref rid="B14-jdb-13-00017" ref-type="bibr">14</xref>,<xref rid="B15-jdb-13-00017" ref-type="bibr">15</xref>]. The association between IVC and adverse cardiometabolic outcomes is not fully understood. Studies in mice show that the duration of embryo culture differentially affects cardiovascular and metabolic health, but only in male offspring [<xref rid="B16-jdb-13-00017" ref-type="bibr">16</xref>]. Moreover, a number of preclinical animal studies have shown outcomes such as large offspring syndrome, organ defects, and epigenetic changes in <italic toggle="yes">IGF2R</italic>, through which IVC may impact cardiovascular physiology [<xref rid="B9-jdb-13-00017" ref-type="bibr">9</xref>,<xref rid="B17-jdb-13-00017" ref-type="bibr">17</xref>]. However, recent studies in both humans and animals have reported no alterations in some cardiovascular outcomes from childhood to adulthood of individuals conceived through IVC [<xref rid="B7-jdb-13-00017" ref-type="bibr">7</xref>,<xref rid="B18-jdb-13-00017" ref-type="bibr">18</xref>,<xref rid="B19-jdb-13-00017" ref-type="bibr">19</xref>]. While this finding is reassuring, continued monitoring and further research are necessary to ensure optimal cardiovascular health in adults conceived through IVC.</p><p>Cardiovascular development in humans closely resembles that in sheep, as both have a prepartum surge in cortisol and thyroid hormones that promotes the maturation of cardiomyocytes before birth [<xref rid="B20-jdb-13-00017" ref-type="bibr">20</xref>,<xref rid="B21-jdb-13-00017" ref-type="bibr">21</xref>,<xref rid="B22-jdb-13-00017" ref-type="bibr">22</xref>,<xref rid="B23-jdb-13-00017" ref-type="bibr">23</xref>,<xref rid="B24-jdb-13-00017" ref-type="bibr">24</xref>]. To initiate glucocorticoid (GC) signaling, cortisol must bind to glucocorticoid receptors (GRs), which then promote or repress the transcriptional regulation of various genes [<xref rid="B25-jdb-13-00017" ref-type="bibr">25</xref>,<xref rid="B26-jdb-13-00017" ref-type="bibr">26</xref>]. In sheep, multiple GR isoforms have been identified in the placenta and lungs [<xref rid="B27-jdb-13-00017" ref-type="bibr">27</xref>,<xref rid="B28-jdb-13-00017" ref-type="bibr">28</xref>,<xref rid="B29-jdb-13-00017" ref-type="bibr">29</xref>]. More recently, we identified five distinct isoforms in the fetal sheep heart [<xref rid="B30-jdb-13-00017" ref-type="bibr">30</xref>]; however, the associated signaling pathways within the heart remain largely unexplored. While the prenatal surge in cortisol is known to increase mitochondrial abundance in skeletal muscle [<xref rid="B31-jdb-13-00017" ref-type="bibr">31</xref>], its effects on the heart&#x02019;s mitochondrial profile and associated pathways remain less well studied. Mitochondria play a vital role in producing ATP through the process of oxidative phosphorylation (OXPHOS), consisting of complexes 1 to 5 of the electron transport chain (ETC) [<xref rid="B32-jdb-13-00017" ref-type="bibr">32</xref>,<xref rid="B33-jdb-13-00017" ref-type="bibr">33</xref>], which is particularly important for the heart. The heart&#x02019;s primary fuel source shifts from glucose during fetal life to free fatty acids in adulthood, a process that involves glucose transporters (i.e., GLUT-1, and GLUT-4) and fatty acid uptake molecules such as CD36 and CPTI [<xref rid="B34-jdb-13-00017" ref-type="bibr">34</xref>,<xref rid="B35-jdb-13-00017" ref-type="bibr">35</xref>]. Cardiac contraction is crucial for delivering blood throughout the body, a process regulated tightly by the interaction between the sarcoendoplasmic reticulum calcium ATPase (SERCA) and phospholamban (PLN) proteins [<xref rid="B36-jdb-13-00017" ref-type="bibr">36</xref>].</p><p>Elevated plasma cortisol concentrations that occur in the presence of prenatal stress or hormone treatments commonly linked to IVC affect fetal heart development [<xref rid="B37-jdb-13-00017" ref-type="bibr">37</xref>,<xref rid="B38-jdb-13-00017" ref-type="bibr">38</xref>,<xref rid="B39-jdb-13-00017" ref-type="bibr">39</xref>]. Despite advances in ARTs, there remains a gap in our knowledge of whether <italic toggle="yes">in vitro</italic> embryo culture and transfer have lasting impacts on postnatal cardiometabolic profile. Therefore, we hypothesized that IVC in the absence or presence of human serum along with methionine supplementation, an intervention aimed at replenishing the methylation levels, will impact cardiac metabolism in sheep offspring in a sex-specific manner. We particularly focused on cardiac hormone concentrations, the expression of GR isoforms, and molecular markers of cardiac metabolism and contractility.</p></sec><sec id="sec2-jdb-13-00017"><title>2. Materials and Methods</title><sec id="sec2dot1-jdb-13-00017"><title>2.1. Animal Ethics</title><p>The study was conducted according to the IMVS/University of South Australia (#110/07) and the Primary Industries and Resources South Australia (#12/09) Animal Ethics Committee and complied with the Australian code of practice for the care and use of animals for scientific purposes. All investigators adhered to the ethical principles and reporting standards for animal experiments as outlined by Grundy et al. [<xref rid="B40-jdb-13-00017" ref-type="bibr">40</xref>] and followed the 3Rs principles, particularly regarding the reduction in animal use in research [<xref rid="B41-jdb-13-00017" ref-type="bibr">41</xref>]. The ARRIVE guidelines were also applied where relevant [<xref rid="B42-jdb-13-00017" ref-type="bibr">42</xref>].</p></sec><sec id="sec2dot2-jdb-13-00017"><title>2.2. Animals and Experimental Design</title><p>All animals were fed 100% of nutritional requirements (7.6 MJ/day for the maintenance of a 64 kg non-pregnant ewe) defined by the Agricultural and Food Research Council [<xref rid="B43-jdb-13-00017" ref-type="bibr">43</xref>]. In order to increase the ovulation rate, donor ewes received a concentrated diet (10.6 MJ/kg DM and 151 g/kg of crude protein) supplemented with 350 g of peas/day for 14 days prior to ovulation. Synchronization and superovulation techniques were induced in the donor ewes according to standard procedures as previously defined [<xref rid="B44-jdb-13-00017" ref-type="bibr">44</xref>,<xref rid="B45-jdb-13-00017" ref-type="bibr">45</xref>,<xref rid="B46-jdb-13-00017" ref-type="bibr">46</xref>]. Ewes were treated with progestagen pessaries (45 mg flugestone acetate; Intervet, France) for 12 days. Commencing 48 h prior to pessary removal, 9.5 mL of follicle-stimulating hormone (FSH; 190 mg NIH-FSH-P1 standard, Follotropin, Bioniche Inc., Belleville, ON, Canada) was administered as two daily injections over three days with 500 IU of equine chorionic gonadotropin (eCG; Pregnecol, Bioniche Inc., Belleville, ON, Canada) administered at the time as the last FSH injection. Twenty-seven hours after pessary removal, synthetic gonadotropin-releasing hormone (GnRH; 30 &#x003bc;g, Fertagyl, Intervet, France) was administered. Both intermediate and recipient ewes were synchronized using progestagen pessary treatment over 12 days, with 400 IU of eCG (Pregnecol, Bioniche Inc., Canada) being administered at the time of pessary removal. The ovulatory cycles of the recipient ewes were synchronized with the ovulatory cycles of donor animals (&#x000b1;12 h) [<xref rid="B4-jdb-13-00017" ref-type="bibr">4</xref>,<xref rid="B47-jdb-13-00017" ref-type="bibr">47</xref>].</p><p>Eighteen hours after the administration of GnRH treatment, donor ewes were artificially inseminated with fresh semen obtained from a proven fertile ram. Approximately 20 &#x000d7; 10<sup>6</sup> spermatozoa were deposited into the lumen of each uterine horn using a laparoscope. The same ram was employed for all replicates and breeding of naturally mated (NM) ewes. Oviducts were flushed ~12&#x02013;17 h after the anticipated median time of ovulation to collect zygotes [<xref rid="B44-jdb-13-00017" ref-type="bibr">44</xref>,<xref rid="B47-jdb-13-00017" ref-type="bibr">47</xref>]. These zygotes were either transferred immediately to an intermediate recipient (ET) or subjected to <italic toggle="yes">in vitro</italic> culture in a defined synthetic oviductal fluid medium [<xref rid="B48-jdb-13-00017" ref-type="bibr">48</xref>]. The culture conditions included absence of human serum (<italic toggle="yes">in vitro</italic> culture, IVC), presence of human serum (IVCHS), or presence of human serum with methionine supplementation (IVCHS+M) until day 6 (day 0 = day of laparoscopic insemination). Ewes in the NM group were naturally mated to give 5 experimental groups [<xref rid="B7-jdb-13-00017" ref-type="bibr">7</xref>]. Zygotes randomly chosen for in vivo culture were transferred to intermediate recipients through mid-ventral laparotomy (7 to 22 embryos per recipient; 1 recipient per replicate) [<xref rid="B49-jdb-13-00017" ref-type="bibr">49</xref>]. Synthetic oviduct fluid medium was prepared as previously outlined [<xref rid="B48-jdb-13-00017" ref-type="bibr">48</xref>,<xref rid="B50-jdb-13-00017" ref-type="bibr">50</xref>]. The IVC medium was a combination of SOF enriched with bovine serum albumin (4 mg/mL) and amino acids at concentrations similar to those found in oviduct fluid. The IVCHS medium consisted of a mixture of IVC medium and 20% human serum (HS). Fresh HS was prepared for each replicate. To obtain HS, 10 mL of whole venous blood was collected from a male subject and immediately centrifuged at 2000&#x000d7; <italic toggle="yes">g</italic> for 20 min, allowing plasma to clot and serum to be extracted by compressing the clot. Serum was then heat-inactivated at 56.0 &#x000b0;C for 30 min, filtered, and stored at 4.0 &#x000b0;C. The IVCHS medium was created by mixing 16 mL of IVC medium with 4 mL of HS, resulting in a final concentration of 20% HS. For the IVCHS+M medium, 5000 &#x003bc;M of methionine (Sigma&#x02013;Aldrich, St. Louis, MA, USA) was added as a supplement, representing the maximum amount soluble in the medium. Zygotes assigned to the embryo culture groups (IVC, IVCHS, and IVCHS+M) underwent three washes in their respective medium. They were then transferred to wells in a 4-well culture dish (Thermo Fisher Scientific, Waltham, MA, USA), each containing 600 &#x003bc;L of the designated medium (IVC, IVCHS, or IVCHS+M), covered with 300 &#x003bc;L of sterile mineral oil (Sigma), and cultured for 6 days. <italic toggle="yes">In vitro</italic> embryo culture was conducted in an environment with 5% CO<sub>2</sub>, 5% O<sub>2</sub>, and 90% N<sub>2</sub>, maintained at 38.5 &#x000b0;C, with groups comprising 12&#x02013;15 embryos. Recipient ewes were randomly assigned to one of four treatment groups: ET (<italic toggle="yes">n</italic> = 11), IVC (<italic toggle="yes">n</italic> = 20), IVCHS (<italic toggle="yes">n</italic> = 11), and IVCHS+M (<italic toggle="yes">n</italic> = 11) [<xref rid="B7-jdb-13-00017" ref-type="bibr">7</xref>]. On day 6, single embryos from these groups were transferred via laparoscopy to the uterine horn ipsilateral to an ovary containing a corpus luteum. The control group comprised naturally mated ewes (NM; <italic toggle="yes">n</italic> = 9) carrying singleton fetuses. The feed allowance per singleton pregnancy was progressively increased by 15% every 10 days from gestational day 115 until the ewes naturally gave birth [<xref rid="B7-jdb-13-00017" ref-type="bibr">7</xref>].</p></sec><sec id="sec2dot3-jdb-13-00017"><title>2.3. Post-Mortem and Tissue Collection</title><p>At 6 months of age, lambs were humanely killed with an overdose of sodium pentobarbitone (150 mg/kg, Virbac Pty Ltd., Peakhurst, NSW, Australia). The hearts were dissected and weighed, and samples were snap frozen in liquid nitrogen, stored at &#x02212;80 &#x000b0;C for subsequent molecular studies, or fixed in 4% paraformaldehyde for histological analysis.</p></sec><sec id="sec2dot4-jdb-13-00017"><title>2.4. Quantification of Cardiac mRNA Expression</title><p>RNA extraction from LV tissue (NM = 5 male (M), 4 female (F); ET = 5M, 5F; IVC = 5M, 6F; IVCHS = 4M, 5F; IVCHS+M = 5M, 4F) was performed using QIAzol reagent (Qiagen, Hilden, Germany) with a tissue homogenizer (TissueLyser LT, Qiagen, Hilden, Germany), followed by purification using the RNeasy Mini Kit (Qiagen, Zurich, Switzerland). The quality and concentration of RNA were evaluated by measuring absorbance at 260 and 280 nm, and RNA integrity was verified using agarose gel electrophoresis. cDNA was then synthesized from 1 &#x003bc;g of RNA via reverse transcription using Superscript III and random hexamers (Invitrogen Australia Pty Ltd., Mt Waverley, VIC, Australia). Negative controls without RNA or Superscript III were included to detect potential DNA or reagent contamination [<xref rid="B51-jdb-13-00017" ref-type="bibr">51</xref>]. All essential details regarding our procedure have been included, following MIQE guidelines [<xref rid="B52-jdb-13-00017" ref-type="bibr">52</xref>]. Quantitative real-time reverse transcription-PCR was employed to assess the expression of target genes relative to three housekeeping genes: <italic toggle="yes">HPRT</italic> [<xref rid="B53-jdb-13-00017" ref-type="bibr">53</xref>], <italic toggle="yes">PGK1</italic> [<xref rid="B54-jdb-13-00017" ref-type="bibr">54</xref>], and <italic toggle="yes">GAPDH</italic> [<xref rid="B54-jdb-13-00017" ref-type="bibr">54</xref>]. This analysis was conducted on a ViiA7 Fast Real-time PCR system (Applied Biosystems, Waltham, MA, USA). The selection of housekeeping genes was based on their stability across treatment groups, as determined using the GeNorm algorithm [<xref rid="B53-jdb-13-00017" ref-type="bibr">53</xref>,<xref rid="B55-jdb-13-00017" ref-type="bibr">55</xref>]. The primer sets for target genes included the following markers of cardiac metabolism: <italic toggle="yes">GLUT-4</italic>, <italic toggle="yes">GSK3-&#x003b2;</italic>, <italic toggle="yes">PC</italic>, <italic toggle="yes">ACC</italic>, <italic toggle="yes">CPTI</italic>, <italic toggle="yes">CD36</italic>, <italic toggle="yes">PPAR&#x003b1;</italic>, <italic toggle="yes">PPAR&#x003b3;</italic>, <italic toggle="yes">PDK-4</italic>, and <italic toggle="yes">PGC-1&#x003b1;</italic> [<xref rid="B56-jdb-13-00017" ref-type="bibr">56</xref>,<xref rid="B57-jdb-13-00017" ref-type="bibr">57</xref>,<xref rid="B58-jdb-13-00017" ref-type="bibr">58</xref>]. In each qRT-PCR reaction well, there were 3 &#x003bc;L of Fast SYBR Green Master Mix (Applied Biosystems), 0.8 &#x003bc;L of H<sub>2</sub>O, 0.6 &#x003bc;L each of forward and reverse primer (GeneWorks, SA, Australia) for the target genes, and 1 &#x003bc;L of diluted relevant cDNA. Each cDNA sample was run in triplicate for every gene, with no-cDNA controls included in each run to check for reagent contamination. Data analysis was performed using DataAssist Software v3.0 (Applied Biosystems, Waltham, MA, USA), and results were reported as mean normalized expression (MNE) [<xref rid="B59-jdb-13-00017" ref-type="bibr">59</xref>,<xref rid="B60-jdb-13-00017" ref-type="bibr">60</xref>].</p></sec><sec id="sec2dot5-jdb-13-00017"><title>2.5. Quantification of Cardiac Protein Expression</title><p>Approximately 100 mg of LV tissue (NM = 5M, 4F; ET = 5M, 5F; IVC = 5M, 6F; IVCHS = 4M, 5F; IVCHS+M = 5M, 4F) was sonicated (John Morris Scientific, Chatswood, NSW, Australia) in lysis buffer containing tris HCl (50 mM), NaCl (150 Mm), NP-40 (1%), sodium orthovanadate (1 mM), sodium fluoride (30 mM), sodium pyrophosphate (10 mM), EDTA (10 mM), and protease inhibitor (1 tablet/20 mL buffer; Complete Mini, Roche). The suspensions were then centrifuged (Eppendorf Centrifuge 5415, Crown Scientific, NSW, Australia) for 14 min at 14,300&#x000d7; <italic toggle="yes">g</italic> and 4 &#x000b0;C. Protein content of the extracts was quantified using a Micro BCA Protein Assay Kit (PIERCE, Thermo Fisher Scientific, Waltham, MA, USA), with bovine serum albumin (2 mg/mL stock solution) used to generate the standard curve. Extracted protein (5 mg/mL) was resolved using SDS-PAGE gels, which were stained with Coomassie blue. No significant differences in the abundance of major proteins were observed between samples [<xref rid="B53-jdb-13-00017" ref-type="bibr">53</xref>,<xref rid="B57-jdb-13-00017" ref-type="bibr">57</xref>,<xref rid="B61-jdb-13-00017" ref-type="bibr">61</xref>]. Due to the large number of samples and to have the power to test for an effect of sex, males and females were randomly allocated across two gels, and then each animal was normalized to an internal control (pooled sample) for each gel. The separated proteins were then transferred onto a nitrocellulose membrane (0.45 &#x000b5;m; Hybond ECL, GE Healthcare, Mascot, NSW, Australia). To check the quality of the transfer and stain the total protein, the membranes were stained with Ponceau S solution (0.1% (w/v) in 5% acetic acid (Sigma-Aldrich, St. Louis, MO, USA), after which membranes were rinsed prior to blocking in 5% BSA diluted in tris-buffered saline with 1% Tween (TBS-T) for 1 h at room temperature to block non-specific binding. Afterward, they were washed with TBS-T (3 &#x000d7; 5 min) and then incubated overnight at 4 &#x000b0;C with the appropriate primary antibody. Specific proteins were targeted using the following primary antibodies: total OXPHOS (1:500, #ab110413, Abcam, Cambridge, UK), PGC-1&#x003b1; (1:1000, #2178S, Cell Signaling Technology, Danvers, MA, USA), MitoBiogenesis cocktail (1: 250, #ab123545, Abcam), Mn-SOD (1:1000, #06-984, Merk, Darmstadt, Germany), NOX-2 (1:5000, #ab129068, Abcam), IRS-1 (1:1000, #3194, Cell Signaling Technology), p-IRS-1 (Ser789) (1:1000, #2389S, Cell Signaling Technology), AS160 (1:1000, #2670S, Cell Signaling Technology), p-AS160 (Thr642) (1:1000, #4288S, Cell Signaling Technology), GLUT-4 (1:1000, #ab33780, Abcam), PDK-4 (1:1000, #PA5-79800, Invitrogen), CD36 (1:1000, #ab133625, Abcam), CPTI (1:1000, sc-98834, Santa Cruz Biotechnology, Dallas, TX, USA), CaMKII (1:1000, #3362S, Cell Signaling Technology), p-CaMKII (Thr286) (1:1000, #sc-32289, Santa Cruz Biotechnology), Phospholamban (1:1000, #8495, Cell Signaling Technology), p-Phospholamban (Ser16/Thr17) (1:1000, #8496S, Cell Signaling Technology), SERCA2 ATPase (1:1000, #ab137020, Abcam, Cambridge, UK), Troponin I (1:1000, #4002, Cell Signaling Technology), p-Troponin I (Ser23/24) (1:1000, #4004S, Cell Signaling Technology), and GR-total (1:1000, #A303-491A, Bethyl Laboratories, Montgomery, TX, USA) as previously described [<xref rid="B27-jdb-13-00017" ref-type="bibr">27</xref>,<xref rid="B54-jdb-13-00017" ref-type="bibr">54</xref>,<xref rid="B62-jdb-13-00017" ref-type="bibr">62</xref>,<xref rid="B63-jdb-13-00017" ref-type="bibr">63</xref>,<xref rid="B64-jdb-13-00017" ref-type="bibr">64</xref>,<xref rid="B65-jdb-13-00017" ref-type="bibr">65</xref>,<xref rid="B66-jdb-13-00017" ref-type="bibr">66</xref>,<xref rid="B67-jdb-13-00017" ref-type="bibr">67</xref>]. All antibodies were prepared in 5% BSA in TBS-T and diluted to their final concentrations as per the manufacturer&#x02019;s recommendations. The membranes were washed again with TBS-T (3 &#x000d7; 5 min) before being incubated for 1 h at room temperature with the appropriate Horse Radish peroxidase-labeled secondary IgG antibody (1:2000, anti-mouse #7076, anti-rabbit #7054, Cell Signaling Technology). Reactive proteins were detected using enhanced chemiluminescence with SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Waltham, MA, USA). The Western blot was captured using the ImageQuant LAS 4000 (GE Healthcare, Mascot, NSW, Australia), and protein abundance was quantified through densitometry using the ImageQuant TL 8.1 software (GE Healthcare, Mascot, NSW, Australia). The abundance of target proteins was adjusted relative to Ponceau S staining or specific reference proteins, vinculin (1:2000, #18799S, Cell Signaling Technology) or &#x003b2;-tubulin (1:1000, # 5346, Cell Signaling Technology).</p></sec><sec id="sec2dot6-jdb-13-00017"><title>2.6. Quantification of Cardiac Concentration of Glucocorticoid and Thyroid Hormones</title><p>Tissue hormone concentrations were measured using liquid chromatography (LC; Shimadzu Nexera XR, Shimadzu, Japan) combined with a SCIEX 6500 Triple-Quad system (MS/MS; SCIEX, US) following a modified protocol [<xref rid="B35-jdb-13-00017" ref-type="bibr">35</xref>,<xref rid="B68-jdb-13-00017" ref-type="bibr">68</xref>,<xref rid="B69-jdb-13-00017" ref-type="bibr">69</xref>]. Initially, LV tissue (NM = 5M, 3F; ET = 5M, 5F; IVC = 5M, 6F; IVCHS = 4M, 5F; IVCHS+M = 5M, 4F) was homogenized in 500 &#x003bc;L 0.9% NaCl at 50 Hz for 2 min and then centrifuged at 12,000&#x000d7; <italic toggle="yes">g</italic> for 10 min at 4 &#x000b0;C. The supernatant (100 &#x003bc;L) was added to 300 &#x003bc;L acetonitrile containing the 50 ng/mL internal standard (cortisol-9,11,12,12-d4; Toronto Research Chemicals, Toronto, ON, Canada), vortexed for 1 min, and then centrifuged at 12,000&#x000d7; <italic toggle="yes">g</italic> for 10 min. The supernatant was transferred to a fresh Eppendorf tube, and the remaining pellet was resuspended in 300 &#x003bc;L of ethyl acetate. The mixture was vortexed for 1 min and then centrifuged at 12,000&#x000d7; <italic toggle="yes">g</italic> for 10 min. The supernatant was mixed with acetonitrile, gently inverted, and then evaporated to dryness using the GeneVac EZ-2 Evaporating System (GeneVac, Ipswich, UK). Dried samples were reconstituted in 50% methanol and then injected onto an ACQUITY UPLC BEH C18 Column (130 &#x000c5;, 1.7 &#x000b5;m, 2.1 mm &#x000d7; 100 mm (Waters Corp, Milford, MA, USA)). Mobile phases were 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). The flow rate was 0.3 mL/min, and mobile phase B was initially 10%, increased linearly to 90% over 10 min, and then held at 90% for 2 min, after which it returned to 10% for 3 min prior to injection of the next sample. Hormone concentrations were determined by integrating the data with a standard curve that ranged from 0.05 to 100 ng/mL. The conditions for detecting the analytes were as previously described [<xref rid="B68-jdb-13-00017" ref-type="bibr">68</xref>].</p></sec><sec id="sec2dot7-jdb-13-00017"><title>2.7. Quantification of Cardiac Glycogen and Collagen Staining</title><p>Paraffin-embedded blocks of LV tissue, fixed with paraformaldehyde (NM = 5M, 4F; ET = 5M, 5F; IVC = 5M, 6F; IVCHS = 4M, 5F; IVCHS+M = 5M, 3F), were sectioned at 5 &#x003bc;m using a rotary microtome and mounted onto superfrost slides (VWR International, Radnor, PA, USA). Periodic acid&#x02013;Schiff (PAS; a marker of glycogen content) and Masson&#x02019;s trichrome (a marker of collagen content) staining was performed by University of Adelaide Histology Services. The slides were scanned at 40&#x000d7; magnification with a NanoZoomer-XR (Hamamatsu, Shizuoka, Japan) to capture images of the entire slides. PAS slides were analyzed with Fiji/ImageJ software (version 1.54f, NIH, Bethesda, MD, USA) using the color saturation threshold tool at 20&#x000d7; magnification, with five frames taken 1 mm apart. Masson&#x02019;s trichrome slides were assessed using the Visiopharm software suite (version 2020.08, Denmark) with a custom threshold application at 10&#x000d7; magnification, covering the entire slide. Quantification of staining was validated through visual examination by a trained individual who was blinded to the treatment groups [<xref rid="B69-jdb-13-00017" ref-type="bibr">69</xref>,<xref rid="B70-jdb-13-00017" ref-type="bibr">70</xref>].</p></sec><sec id="sec2dot8-jdb-13-00017"><title>2.8. Statistical Analyses</title><p>Statistical analyses were conducted using GraphPad Prism 10 (GraphPad Software, Inc., Boston, MA, USA). Some samples were excluded from the analysis due to systematic or technical errors (hormone assay) or the absence of fixed tissue samples (histology). In the Western blot analysis, any non-quantifiable bands (due to an artifact on the band/s), were excluded and marked with an X on the blots. Up to one outlier per group was removed if identified using the Dixon Q test (&#x003b1; = 0.05; Minitab (v22.2.1)). The number of samples used for each analysis is provided in the table and figure legends. Data normality was tested using the Shapiro&#x02013;Wilk test. The effects of treatment, sex, and their interaction were assessed with two-way ANOVA followed by Tukey&#x02019;s multiple comparisons test. Data are presented as mean &#x000b1; SD, and <italic toggle="yes">p</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3-jdb-13-00017"><title>3. Results</title><sec id="sec3dot1-jdb-13-00017"><title>3.1. IVC Did Not Impact Cardiac Hormones and Glucocorticoid Receptors</title><p>The cardiac hormone concentration of cortisol, cortisone, cortisol:cortisone ratio, and corticosterone were not affected by treatment (<xref rid="jdb-13-00017-f001" ref-type="fig">Figure 1</xref>A&#x02013;D). There were main sex effects in cortisol (<italic toggle="yes">P<sub>sex</sub></italic> = 0.0006; <xref rid="jdb-13-00017-f001" ref-type="fig">Figure 1</xref>A) and cortisol:cortisone (<italic toggle="yes">P<sub>sex</sub></italic> = 0.0022; <xref rid="jdb-13-00017-f001" ref-type="fig">Figure 1</xref>D) concentrations, such that females had higher concentrations compared to males. Testosterone concentration was affected by treatment (<italic toggle="yes">P<sub>trt</sub></italic> = 0.0044) and sex (<italic toggle="yes">P<sub>sex</sub></italic> &#x0003c; 0.0001), such that NM and IVCHS males had higher concentrations compared to males in the other groups (<xref rid="jdb-13-00017-f001" ref-type="fig">Figure 1</xref>E). Within each group, testosterone concentration was also higher in the males compared to the females (<xref rid="jdb-13-00017-f001" ref-type="fig">Figure 1</xref>E). The concentrations of T3, T4, and T3: T4 ratio were not affected by treatment or sex (<xref rid="jdb-13-00017-f001" ref-type="fig">Figure 1</xref>F&#x02013;H). The protein expressions of GR&#x003b1;-A, GR&#x003b1;-C, and GR&#x003b1;-D3 were not affected by treatment or sex (<xref rid="jdb-13-00017-f001" ref-type="fig">Figure 1</xref>I&#x02013;K).</p></sec><sec id="sec3dot2-jdb-13-00017"><title>3.2. IVC Reduced Mitochondrial Abundance and OXPHOS, Particularly in Males</title><p>The cardiac protein expression of OXPHOS complex 1 was affected by treatment (<italic toggle="yes">P<sub>trt</sub></italic> = 0.0428) and sex (<italic toggle="yes">P<sub>sex</sub></italic> = 0.0192), with males having higher expression compared to females and the expression in the NM group being higher than in the IVCHS group (<italic toggle="yes">p</italic> = 0.0439; <xref rid="jdb-13-00017-f002" ref-type="fig">Figure 2</xref>A). Complex 2 was not affected by treatment or sex (<xref rid="jdb-13-00017-f002" ref-type="fig">Figure 2</xref>B). Complex 3 expression was higher in males compared to females (<italic toggle="yes">P<sub>sex</sub></italic> = 0.0194; <xref rid="jdb-13-00017-f002" ref-type="fig">Figure 2</xref>C). Complex 4 was affected by treatment (<italic toggle="yes">P<sub>trt</sub></italic> = 0.0116; <xref rid="jdb-13-00017-f002" ref-type="fig">Figure 2</xref>D), with expression higher in the NM group compared to the ET group (<italic toggle="yes">p</italic> = 0.0396), IVCHS (<italic toggle="yes">p</italic> = 0.0235) and IVCHS+M (<italic toggle="yes">p</italic> = 0.0177) groups. Complex 5 was not affected by treatment or sex (<xref rid="jdb-13-00017-f002" ref-type="fig">Figure 2</xref>E). Mitochondrial abundance (MT-COXI:SDHA ratio) was higher in the males of the NM group than males of the ET (<italic toggle="yes">p</italic> = 0.0005), IVC (<italic toggle="yes">p</italic> = 0.0013), IVCHS (<italic toggle="yes">p</italic> = 0.0020), and IVCHS+M (<italic toggle="yes">p</italic> = 0.0039; <xref rid="jdb-13-00017-f002" ref-type="fig">Figure 2</xref>F) groups. Within the NM group, mitochondrial abundance was also higher in males compared to females (<italic toggle="yes">p</italic> = 0.0005; <xref rid="jdb-13-00017-f002" ref-type="fig">Figure 2</xref>F).</p></sec><sec id="sec3dot3-jdb-13-00017"><title>3.3. IVC Altered a Marker of Cardiac Metabolic Switch</title><p>The cardiac protein expression of p-IRS-1:IRS-1 was not affected by treatment or sex (<xref rid="jdb-13-00017-f003" ref-type="fig">Figure 3</xref>A). The expression of p-AS160:AS160 was lower in NM males compared to IVCHS males (<italic toggle="yes">p</italic> = 0.0214; <xref rid="jdb-13-00017-f003" ref-type="fig">Figure 3</xref>B). Cardiac expression of p-AS160:AS160 was also higher in IVC (<italic toggle="yes">p</italic> = 0.0414) and IVCHS (<italic toggle="yes">p</italic> = 0.0122) males compared to the females (<xref rid="jdb-13-00017-f003" ref-type="fig">Figure 3</xref>B). mRNA or protein expression of GLUT-4 and mRNA expression of <italic toggle="yes">GSK3&#x003b2;</italic> were not affected by treatment or sex (<xref rid="jdb-13-00017-f003" ref-type="fig">Figure 3</xref>C&#x02013;E). Protein expression of PDK-4, a marker of cardiac metabolic switch, was affected by treatment (<italic toggle="yes">P<sub>trt</sub></italic> = 0.0372), with expression higher in the NM group than in the IVCHS+M group (<italic toggle="yes">p</italic> = 0.0229; <xref rid="jdb-13-00017-f003" ref-type="fig">Figure 3</xref>F).</p></sec><sec id="sec3dot4-jdb-13-00017"><title>3.4. IVC Did Not Alter Markers of Cardiac Fatty Acid Metabolism</title><p>The cardiac mRNA and protein expression of CD36 was not affected by treatment or sex (<xref rid="jdb-13-00017-f004" ref-type="fig">Figure 4</xref>A,B). mRNA expression of <italic toggle="yes">CPTI</italic> was higher in females than males (<italic toggle="yes">P<sub>sex</sub></italic> = 0.0060; <xref rid="jdb-13-00017-f004" ref-type="fig">Figure 4</xref>C), while CPTI protein expression was not affected by treatment or sex (<xref rid="jdb-13-00017-f004" ref-type="fig">Figure 4</xref>D). mRNA expression of <italic toggle="yes">PPAR&#x003b1;</italic> was higher in NM females compared to IVCHS+M females (<italic toggle="yes">p</italic> = 0.0008) and higher in NM females compared to NM males (<italic toggle="yes">p</italic> = 0.0176; <xref rid="jdb-13-00017-f004" ref-type="fig">Figure 4</xref>E). mRNA expression of <italic toggle="yes">PPAR&#x003b3;</italic>, <italic toggle="yes">ACC</italic>, and <italic toggle="yes">PC</italic> was not affected by treatment or sex (<xref rid="jdb-13-00017-f004" ref-type="fig">Figure 4</xref>F&#x02013;H).</p></sec><sec id="sec3dot5-jdb-13-00017"><title>3.5. IVC Reduced a Marker of Cardiac Antioxidant Defense, with No Effect on Markers of Contractility</title><p>The cardiac protein expression of p-CAMKII:CAMKII and p-PLN:PLN was not affected by treatment or sex (<xref rid="jdb-13-00017-f005" ref-type="fig">Figure 5</xref>A,B). The protein expression of SERCA2 was higher in NM males compared to NM females (<italic toggle="yes">p</italic> = 0.0105; <xref rid="jdb-13-00017-f005" ref-type="fig">Figure 5</xref>C). The protein expression of p-TroponinI:TroponinI was not affected by treatment or sex (<xref rid="jdb-13-00017-f005" ref-type="fig">Figure 5</xref>D). mRNA expression of <italic toggle="yes">PGC-1&#x003b1;</italic> was not affected by treatment or sex (<xref rid="jdb-13-00017-f005" ref-type="fig">Figure 5</xref>E), while its protein expression was higher in females compared to males (<italic toggle="yes">P<sub>sex</sub></italic> = 0.0039; <xref rid="jdb-13-00017-f005" ref-type="fig">Figure 5</xref>F). Mn-SOD, a marker of cardiac antioxidant defense, was affected by treatment (<italic toggle="yes">P<sub>trt</sub></italic> = 0.0173), such that the expression in the NM group was higher than in the IVCHS+M group (<italic toggle="yes">p</italic> = 0.0139; <xref rid="jdb-13-00017-f005" ref-type="fig">Figure 5</xref>G). Protein expression of NOX-2 was not affected by treatment or sex (<xref rid="jdb-13-00017-f005" ref-type="fig">Figure 5</xref>H).</p></sec><sec id="sec3dot6-jdb-13-00017"><title>3.6. IVC Did Not Alter Cardiac Glycogen and Collagen Content</title><p>The cardiac content of glycogen and collagen was not affected by treatment or sex (<xref rid="jdb-13-00017-f006" ref-type="fig">Figure 6</xref>K,L).</p></sec></sec><sec sec-type="discussion" id="sec4-jdb-13-00017"><title>4. Discussion</title><p>This study revealed that IVC downregulated cardiac mitochondrial protein abundance in males, suggesting potential sex-specific disruptions to cardiac metabolism and function. Additionally, IVC reduced cardiac expression of OXPHOS complexes 1 and 4, which may indicate impaired energy production. Hearts from lambs subjected to IVCHS+M exhibited lower protein expression of PDK-4 and Mn-SOD compared to naturally mated controls, pointing to compromised energy efficiency and diminished defense to oxidative stress. These findings highlight the sex-specific and mechanistic impacts of two forms of IVC on postnatal cardiac health.</p><p>We found a sex-related difference in cardiac cortisol concentrations, with females showing higher concentrations compared to males, regardless of treatment. Data on sex-related differences in cardiac cortisol concentrations remain scarce; however, these differences may be influenced by sex hormones, such as estrogen. Research in human and various animal models have demonstrated that estrogen plays a key role in modulating the hypothalamic&#x02013;pituitary&#x02013;adrenal (HPA) axis [<xref rid="B71-jdb-13-00017" ref-type="bibr">71</xref>,<xref rid="B72-jdb-13-00017" ref-type="bibr">72</xref>]. In support of this interpretation, ovariectomy reduces basal cortisol, whereas estrogen replacement therapy increases free cortisol concentrations [<xref rid="B73-jdb-13-00017" ref-type="bibr">73</xref>,<xref rid="B74-jdb-13-00017" ref-type="bibr">74</xref>,<xref rid="B75-jdb-13-00017" ref-type="bibr">75</xref>]. We also found that testosterone concentrations in the heart were higher in males compared to females, which may be associated with cortisol status. Androgens can modulate HPA axis activity [<xref rid="B76-jdb-13-00017" ref-type="bibr">76</xref>], with evidence indicating that testosterone suppresses cortisol concentrations in men [<xref rid="B77-jdb-13-00017" ref-type="bibr">77</xref>]. Furthermore, the lower testosterone concentrations observed in IVC males compared to the control males in this study suggest that IVC may also play a role in modulating this relationship.</p><p>GR isoforms are produced from a single GR gene (<italic toggle="yes">NR3C1</italic>) via alternative splicing and alternative translation initiation [<xref rid="B78-jdb-13-00017" ref-type="bibr">78</xref>]. The human GR gene expresses two major mRNA variants: GR&#x003b1; and GR&#x003b2;. The GR&#x003b1; mRNA further generates multiple isoforms including GR&#x003b1;-A, GR&#x003b1;-B, GR&#x003b1;-C1-3, and GR&#x003b1;-D1-3 [<xref rid="B79-jdb-13-00017" ref-type="bibr">79</xref>,<xref rid="B80-jdb-13-00017" ref-type="bibr">80</xref>]. Multiple GR protein isoforms have been detected in the placenta and lungs of both humans and sheep [<xref rid="B27-jdb-13-00017" ref-type="bibr">27</xref>,<xref rid="B28-jdb-13-00017" ref-type="bibr">28</xref>,<xref rid="B29-jdb-13-00017" ref-type="bibr">29</xref>]; however, their expression and function in the heart are still largely unexplored. Recently, we have identified five GR isoforms (GR&#x003b1;-A, GR-P, GR-A, GR&#x003b1;-D2, and GR&#x003b1;-D3) in the fetal sheep heart, with their expression decreasing as gestational age advances [<xref rid="B30-jdb-13-00017" ref-type="bibr">30</xref>]. Interestingly, the current study identified three isoforms (GR&#x003b1;-A, GR&#x003b1;-C, and GR&#x003b1;-D3) in adult hearts. This difference may reflect developmental regulation of GR isoforms, with certain isoforms being predominantly expressed during fetal development to meet the unique physiological and metabolic demands of the developing heart. Although information on the physiological functions and signaling pathways of each GR isoform is limited, studies have demonstrated that the translational isoforms of GR&#x003b1; (i.e., GR&#x003b1;-D3) exhibit comparable affinity for GCs and a similar ability to interact with glucocorticoid response elements (GREs) upon ligand activation [<xref rid="B81-jdb-13-00017" ref-type="bibr">81</xref>,<xref rid="B82-jdb-13-00017" ref-type="bibr">82</xref>]. The discovery that each GR&#x003b1; translational isoform regulates a distinct transcriptome suggests that cellular responses to GCs depend on the specific isoforms expressed [<xref rid="B80-jdb-13-00017" ref-type="bibr">80</xref>]. For instance, while GR&#x003b1;-A and GR&#x003b1;-B isoforms are the most prevalent GR proteins in many cell types, trabecular meshwork cells in the human eye predominantly express the GR&#x003b1;-C and GR&#x003b1;-D isoforms [<xref rid="B83-jdb-13-00017" ref-type="bibr">83</xref>]. In rodents, the GR&#x003b1;-C isoform is most abundant in the pancreas and colon, while the GR&#x003b1;-D isoform is most abundant in the spleen and lung [<xref rid="B82-jdb-13-00017" ref-type="bibr">82</xref>].</p><p>This study revealed that IVC downregulated cardiac mitochondrial abundance, but only in males. Moreover, cardiac protein expression of OXPHOS complex 1 and 4 was lower in heart from IVC compared to naturally mated offspring. Mitochondria, often referred to as the &#x0201c;powerhouse&#x0201d; of the heart, play a vital role in producing ATP via OXPHOS [<xref rid="B32-jdb-13-00017" ref-type="bibr">32</xref>,<xref rid="B84-jdb-13-00017" ref-type="bibr">84</xref>]. Additionally, these organelles are involved in various signaling pathways associated with the regulation of oxidative stress, inflammation, mitophagy, calcium handling, and apoptosis: all key processes that contribute to cardiac dysfunction under various pathophysiological conditions [<xref rid="B85-jdb-13-00017" ref-type="bibr">85</xref>,<xref rid="B86-jdb-13-00017" ref-type="bibr">86</xref>,<xref rid="B87-jdb-13-00017" ref-type="bibr">87</xref>]. Given the high energy requirements of the cardiac excitation&#x02013;contraction and relaxation cycle, individuals with impaired OXPHOS are at a higher risk of developing heart diseases [<xref rid="B88-jdb-13-00017" ref-type="bibr">88</xref>,<xref rid="B89-jdb-13-00017" ref-type="bibr">89</xref>,<xref rid="B90-jdb-13-00017" ref-type="bibr">90</xref>]. Recent studies have demonstrated that mitochondrial respiration is reduced in the hearts of fetal sheep with fetal growth restriction (FGR), suggesting that FGR increases the risk of developing heart disease and failure in adulthood [<xref rid="B91-jdb-13-00017" ref-type="bibr">91</xref>]. Complex 1 deficiency is the most frequent mitochondrial disorder presenting in childhood and leads to cardiomyopathy later in life [<xref rid="B92-jdb-13-00017" ref-type="bibr">92</xref>]. In line with our findings, Dimasi et al. also found that reduced in utero substrate supply leading to FGR was associated with decreased mitochondrial abundance and protein expression of OXPHOS complexes 2 and 4 in the fetal sheep heart [<xref rid="B35-jdb-13-00017" ref-type="bibr">35</xref>], suggesting altered ATP production. Consistent with the findings of this study, they also found that cardiac mitochondrial abundance was higher in males compared to females, regardless of treatment [<xref rid="B35-jdb-13-00017" ref-type="bibr">35</xref>]. Together, the observed decreases in mitochondrial abundance and OXPHOS complexes suggests that IVC may induce lasting mitochondrial alterations, with males showing greater susceptibility to these effects into adulthood.</p><p>We also found that cardiac protein expression of PDK-4 was lower in the IVCHS+M group compared to natural mate controls. PDK-4 functions as a metabolic switch, altering substrate utilization from glucose to fatty acids [<xref rid="B93-jdb-13-00017" ref-type="bibr">93</xref>,<xref rid="B94-jdb-13-00017" ref-type="bibr">94</xref>]. PDK-1 and PDK-4 are key heart isoenzymes [<xref rid="B95-jdb-13-00017" ref-type="bibr">95</xref>] with distinct sensitivity to environmental stimuli and metabolic intermediates; PDK-1 primarily senses low oxygen, while PDK-4 responds to nutrient deprivation [<xref rid="B96-jdb-13-00017" ref-type="bibr">96</xref>,<xref rid="B97-jdb-13-00017" ref-type="bibr">97</xref>]. In end-stage systolic heart failure patients, protein expression of PDK-1 and PDK-2 remained unchanged in the LV, whereas PDK-4 expression was reduced by more than 60% [<xref rid="B98-jdb-13-00017" ref-type="bibr">98</xref>]. Moreover, several studies have also reported metabolic shifts in heart failure, including reduced oxidative phosphorylation, decreased fatty acid oxidation, and increased reliance on glucose oxidation [<xref rid="B99-jdb-13-00017" ref-type="bibr">99</xref>,<xref rid="B100-jdb-13-00017" ref-type="bibr">100</xref>,<xref rid="B101-jdb-13-00017" ref-type="bibr">101</xref>,<xref rid="B102-jdb-13-00017" ref-type="bibr">102</xref>]. Taken together, the observed reduction in PDK-4 in the IVCHS+M hearts may suggest a metabolic shift favoring glucose oxidation over fatty acid oxidation. This may reflect a programmed disruption to metabolic flexibility, potentially impairing energy efficiency and cardiac performance, suggesting that methionine supplementation to mitigate the effects of IVCHS on heart growth may not be beneficial.</p><p>The cardiac protein expression of Mn-SOD was also lower in IVCHS+M hearts compared to NM controls in the current study. The antioxidant defense system is primarily composed of superoxide dismutase (SOD), catalase, glutathione peroxidases, and peroxiredoxins; deficiencies in these components can lead to oxidative stress [<xref rid="B103-jdb-13-00017" ref-type="bibr">103</xref>]. In mammalian tissues, three isoforms of SOD are found in different locations: CuZn-SOD is located in the cytosol; Mn-SOD is found in the mitochondria; and extracellular SOD is present in the interstitial fluid [<xref rid="B104-jdb-13-00017" ref-type="bibr">104</xref>]. Mitochondrial Mn-SOD is known as a cardioprotective enzyme that protects mitochondria and limits mitochondria-related apoptosis [<xref rid="B105-jdb-13-00017" ref-type="bibr">105</xref>]. A lack of Mn-SOD in mice leads to dilated cardiomyopathy and triggers progressive heart failure due to excessive superoxide production and transcriptional changes in genes linked to heart failure [<xref rid="B106-jdb-13-00017" ref-type="bibr">106</xref>]. Mitochondrial oxidative stress and damage may play a key role in the development and progression of LV remodeling and failure following myocardial infarction [<xref rid="B107-jdb-13-00017" ref-type="bibr">107</xref>]. In the failing ventricular myocardium of end-stage heart failure patients, significant reductions in mitochondrial Mn-SOD protein abundance and activity have been observed [<xref rid="B108-jdb-13-00017" ref-type="bibr">108</xref>]. Taken together, the reduced Mn-SOD abundance in the IVCHS+M hearts suggests impaired mitochondrial defense against oxidative stress, making them more susceptible to mitochondrial dysfunction and damage under physiological or pathological stress conditions. To support this, it has been indicated that during ART procedures, ovarian stimulation and <italic toggle="yes">in vitro</italic> embryo culture can increase oxidative stress, impair mitochondria, and reduce mitochondrial Mn-SOD abundance [<xref rid="B109-jdb-13-00017" ref-type="bibr">109</xref>,<xref rid="B110-jdb-13-00017" ref-type="bibr">110</xref>,<xref rid="B111-jdb-13-00017" ref-type="bibr">111</xref>].</p><p>This study provides valuable insights into the long-term effects of IVC on cardiac metabolism and mitochondrial abundance in adolescent offspring; however, some limitations should be acknowledged. The IVC media used in this study, including human serum and methionine supplementation, are now considered outdated, as serum-free media have become the standard for preimplantation embryo culture across species [<xref rid="B12-jdb-13-00017" ref-type="bibr">12</xref>,<xref rid="B13-jdb-13-00017" ref-type="bibr">13</xref>]. Nonetheless, these findings remain relevant as they reflect IVC practices employed in the past, aligning with the context of human offspring now over 20 years of age. Additionally, the study did not assess mitochondrial OXPHOS activity, ROS production, proton leak, and mitochondrial structure, as these measurements require fresh tissue or specific fixation. Including these analyses in future studies will provide a more comprehensive evaluation of mitochondrial function. Future studies exploring mitochondrial bioenergetics (including ATP production), oxidative stress, and vascular analysis are also necessary to build upon these findings.</p></sec><sec sec-type="conclusions" id="sec5-jdb-13-00017"><title>5. Conclusions</title><p>This study demonstrates that IVC, in the absence or presence of human serum with methionine supplementation, has a significant and sex-specific impact on cardiac metabolism in adolescent sheep. IVC downregulated mitochondrial abundance in male hearts and OXPHOS complexes in both sexes, potentially compromising energy production and cardiac function. Furthermore, reductions in PDK-4 and Mn-SOD protein abundance in the IVCHS+M hearts highlight disruptions in metabolic flexibility and antioxidant defenses, increasing susceptibility to oxidative stress and mitochondrial dysfunction. These findings underscore the lasting effects of IVC on cardiac health and the heightened vulnerability of males to these alterations, emphasizing the need for further research into IVC-induced programming of cardiometabolic health.</p></sec></body><back><ack><title>Acknowledgments</title><p>We acknowledge support in the care of ewes and lambs and tissue collection from members of the Early Origins of Adult Health Research Group. We also thank Vicki L. Clifton for her expert advice on the verification of GR isoforms.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conception or design of the work: S.K.W., D.O.K., I.C.M. and J.L.M. Acquisition or analysis or interpretation of data for the work: R.A., S.L.H., A.S.M., M.P., K.J.B.-L., S.Z., S.M.M., D.O.K., S.K.W., J.M.K., S.R.R., I.C.M., M.D.W., M.C.L. and J.L.M. Drafting the work or revising it critically for important intellectual content: R.A., A.S.M., M.D.W., M.C.L. and J.L.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The animal study protocol was approved by the Animal Ethics Committee of IMVS/University of South Australia (#110/07) and the Primary Industries and Resources South Australia (#12/09).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>All data supporting the results are presented in the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-jdb-13-00017"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wyns</surname><given-names>C.</given-names></name>
<name><surname>De Geyter</surname><given-names>C.</given-names></name>
<name><surname>Calhaz-Jorge</surname><given-names>C.</given-names></name>
<name><surname>Kupka</surname><given-names>M.</given-names></name>
<name><surname>Motrenko</surname><given-names>T.</given-names></name>
<name><surname>Smeenk</surname><given-names>J.</given-names></name>
<name><surname>Bergh</surname><given-names>C.</given-names></name>
<name><surname>Tandler-Schneider</surname><given-names>A.</given-names></name>
<name><surname>Rugescu</surname><given-names>I.</given-names></name>
</person-group><article-title>ART in Europe, 2018: Results generated from European registries by ESHRE</article-title><source>Hum. Reprod. Open</source><year>2022</year><volume>2022</volume><fpage>hoac022</fpage><pub-id pub-id-type="pmid">35795850</pub-id>
</element-citation></ref><ref id="B2-jdb-13-00017"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Castro</surname><given-names>R.C.F.</given-names></name>
<name><surname>Buranello</surname><given-names>T.W.</given-names></name>
<name><surname>Recchia</surname><given-names>K.</given-names></name>
<name><surname>de Souza</surname><given-names>A.F.</given-names></name>
<name><surname>Pieri</surname><given-names>N.C.G.</given-names></name>
<name><surname>Bressan</surname><given-names>F.F.</given-names></name>
</person-group><article-title>Emerging Contributions of Pluripotent Stem Cells to Reproductive Technologies in Veterinary Medicine</article-title><source>J. Dev. Biol.</source><year>2024</year><volume>12</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.3390/jdb12020014</pub-id><pub-id pub-id-type="pmid">38804434</pub-id>
</element-citation></ref><ref id="B3-jdb-13-00017"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Celermajer</surname><given-names>D.S.</given-names></name>
</person-group><article-title>Manipulating nature: Might there be a cardiovascular price to pay for the miracle of assisted conception?</article-title><source>Circulation</source><year>2012</year><volume>125</volume><fpage>1832</fpage><lpage>1834</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.100479</pub-id><pub-id pub-id-type="pmid">22434594</pub-id>
</element-citation></ref><ref id="B4-jdb-13-00017"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Padhee</surname><given-names>M.</given-names></name>
<name><surname>Lock</surname><given-names>M.C.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>Nyengaard</surname><given-names>J.R.</given-names></name>
<name><surname>MacLaughlin</surname><given-names>S.M.</given-names></name>
<name><surname>Kleemann</surname><given-names>D.O.</given-names></name>
<name><surname>Walker</surname><given-names>S.K.</given-names></name>
<name><surname>Kelly</surname><given-names>J.M.</given-names></name>
<etal/>
</person-group><article-title>Sex-specific effects of in vitro culture and embryo transfer on cardiac growth in sheep offspring</article-title><source>J. Mol. Cell. Cardiol. Plus</source><year>2023</year><volume>5</volume><fpage>100039</fpage><pub-id pub-id-type="doi">10.1016/j.jmccpl.2023.100039</pub-id><pub-id pub-id-type="pmid">39802173</pub-id>
</element-citation></ref><ref id="B5-jdb-13-00017"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fern&#x000e1;ndez-Gonzalez</surname><given-names>R.</given-names></name>
<name><surname>Moreira</surname><given-names>P.</given-names></name>
<name><surname>Bilbao</surname><given-names>A.</given-names></name>
<name><surname>Jim&#x000e9;nez</surname><given-names>A.</given-names></name>
<name><surname>P&#x000e9;rez-Crespo</surname><given-names>M.</given-names></name>
<name><surname>Ram&#x000ed;rez</surname><given-names>M.A.</given-names></name>
<name><surname>De Fonseca</surname><given-names>F.R.</given-names></name>
<name><surname>Pintado</surname><given-names>B.</given-names></name>
<name><surname>Guti&#x000e9;rrez-Ad&#x000e1;n</surname><given-names>A.</given-names></name>
</person-group><article-title>Long-term effect of in vitro culture of mouse embryos with serum on mRNA expression of imprinting genes, development, and behavior</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>5880</fpage><lpage>5885</lpage><pub-id pub-id-type="doi">10.1073/pnas.0308560101</pub-id><pub-id pub-id-type="pmid">15079084</pub-id>
</element-citation></ref><ref id="B6-jdb-13-00017"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Padhee</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Lie</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>K.C.</given-names></name>
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>MacLaughlin</surname><given-names>S.M.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>The Periconceptional Environment and Cardiovascular Disease: Does In Vitro Embryo Culture and Transfer Influence Cardiovascular Development and Health?</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>1378</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.3390/nu7031378</pub-id><pub-id pub-id-type="pmid">25699984</pub-id>
</element-citation></ref><ref id="B7-jdb-13-00017"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Padhee</surname><given-names>M.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>MacLaughlin</surname><given-names>S.M.</given-names></name>
<name><surname>Armitage</surname><given-names>J.A.</given-names></name>
<name><surname>Head</surname><given-names>G.A.</given-names></name>
<name><surname>Darby</surname><given-names>J.R.</given-names></name>
<name><surname>Kelly</surname><given-names>J.M.</given-names></name>
<name><surname>Rudiger</surname><given-names>S.R.</given-names></name>
<name><surname>Kleemann</surname><given-names>D.O.</given-names></name>
</person-group><article-title>Impact of in vitro embryo culture and transfer on blood pressure regulation in the adolescent lamb</article-title><source>J. Dev. Orig. Health Dis.</source><year>2021</year><volume>12</volume><fpage>731</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1017/S2040174420001014</pub-id><pub-id pub-id-type="pmid">33185521</pub-id>
</element-citation></ref><ref id="B8-jdb-13-00017"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Talwar</surname><given-names>P.</given-names></name>
</person-group><source>Manual of Assisted Reproductive Technologies and Clinical Embryology</source><publisher-name>JP Medical Ltd.</publisher-name><publisher-loc>Delhi, India</publisher-loc><year>2012</year></element-citation></ref><ref id="B9-jdb-13-00017"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Young</surname><given-names>L.E.</given-names></name>
<name><surname>Fernandes</surname><given-names>K.</given-names></name>
<name><surname>McEvoy</surname><given-names>T.G.</given-names></name>
<name><surname>Butterwith</surname><given-names>S.C.</given-names></name>
<name><surname>Gutierrez</surname><given-names>C.G.</given-names></name>
<name><surname>Carolan</surname><given-names>C.</given-names></name>
<name><surname>Broadbent</surname><given-names>P.J.</given-names></name>
<name><surname>Robinson</surname><given-names>J.J.</given-names></name>
<name><surname>Wilmut</surname><given-names>I.</given-names></name>
<name><surname>Sinclair</surname><given-names>K.D.</given-names></name>
</person-group><article-title>Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture</article-title><source>Nat. Genet.</source><year>2001</year><volume>27</volume><fpage>153</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1038/84769</pub-id><pub-id pub-id-type="pmid">11175780</pub-id>
</element-citation></ref><ref id="B10-jdb-13-00017"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sinclair</surname><given-names>K.D.</given-names></name>
<name><surname>McEvoy</surname><given-names>T.</given-names></name>
<name><surname>Maxfield</surname><given-names>E.</given-names></name>
<name><surname>Maltin</surname><given-names>C.</given-names></name>
<name><surname>Young</surname><given-names>L.</given-names></name>
<name><surname>Wilmut</surname><given-names>I.</given-names></name>
<name><surname>Broadbent</surname><given-names>P.</given-names></name>
<name><surname>Robinson</surname><given-names>J.</given-names></name>
</person-group><article-title>Aberrant fetal growth and development after in vitro culture of sheep zygotes</article-title><source>Reproduction</source><year>1999</year><volume>116</volume><fpage>177</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1530/jrf.0.1160177</pub-id></element-citation></ref><ref id="B11-jdb-13-00017"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farin</surname><given-names>P.W.</given-names></name>
<name><surname>Farin</surname><given-names>C.E.</given-names></name>
</person-group><article-title>Transfer of bovine embryos produced in vivo or in vitro: Survival and fetal development</article-title><source>Biol. Reprod.</source><year>1995</year><volume>52</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1095/biolreprod52.3.676</pub-id><pub-id pub-id-type="pmid">7756461</pub-id>
</element-citation></ref><ref id="B12-jdb-13-00017"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chronopoulou</surname><given-names>E.</given-names></name>
<name><surname>Harper</surname><given-names>J.C.</given-names></name>
</person-group><article-title>IVF culture media: Past, present and future</article-title><source>Hum. Reprod. Update</source><year>2015</year><volume>21</volume><fpage>39</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1093/humupd/dmu040</pub-id><pub-id pub-id-type="pmid">25035437</pub-id>
</element-citation></ref><ref id="B13-jdb-13-00017"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Swain</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Culture media in IVF: Decisions for the laboratory</article-title><source>In Vitro Fertilization: A Textbook of Current and Emerging Methods and Devices</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2019</year><fpage>105</fpage><lpage>119</lpage></element-citation></ref><ref id="B14-jdb-13-00017"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feuer</surname><given-names>S.</given-names></name>
<name><surname>Rinaudo</surname><given-names>P.</given-names></name>
</person-group><article-title>From embryos to adults: A DOHaD perspective on in vitro fertilization and other assisted reproductive technologies</article-title><source>Healthcare</source><year>2016</year><volume>4</volume><elocation-id>51</elocation-id><pub-id pub-id-type="doi">10.3390/healthcare4030051</pub-id><pub-id pub-id-type="pmid">27517965</pub-id>
</element-citation></ref><ref id="B15-jdb-13-00017"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fleming</surname><given-names>T.P.</given-names></name>
<name><surname>Watkins</surname><given-names>A.J.</given-names></name>
<name><surname>Velazquez</surname><given-names>M.A.</given-names></name>
<name><surname>Mathers</surname><given-names>J.C.</given-names></name>
<name><surname>Prentice</surname><given-names>A.M.</given-names></name>
<name><surname>Stephenson</surname><given-names>J.</given-names></name>
<name><surname>Barker</surname><given-names>M.</given-names></name>
<name><surname>Saffery</surname><given-names>R.</given-names></name>
<name><surname>Yajnik</surname><given-names>C.S.</given-names></name>
<name><surname>Eckert</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Origins of lifetime health around the time of conception: Causes and consequences</article-title><source>Lancet</source><year>2018</year><volume>391</volume><fpage>1842</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)30312-X</pub-id><pub-id pub-id-type="pmid">29673874</pub-id>
</element-citation></ref><ref id="B16-jdb-13-00017"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aljahdali</surname><given-names>A.</given-names></name>
<name><surname>Airina</surname><given-names>R.R.I.</given-names></name>
<name><surname>Velazquez</surname><given-names>M.A.</given-names></name>
<name><surname>Sheth</surname><given-names>B.</given-names></name>
<name><surname>Wallen</surname><given-names>K.</given-names></name>
<name><surname>Osmond</surname><given-names>C.</given-names></name>
<name><surname>Watkins</surname><given-names>A.J.</given-names></name>
<name><surname>Eckert</surname><given-names>J.J.</given-names></name>
<name><surname>Smyth</surname><given-names>N.R.</given-names></name>
<name><surname>Fleming</surname><given-names>T.P.</given-names></name>
</person-group><article-title>The duration of embryo culture after mouse IVF differentially affects cardiovascular and metabolic health in male offspring</article-title><source>Hum. Reprod.</source><year>2020</year><volume>35</volume><fpage>2497</fpage><lpage>2514</lpage><pub-id pub-id-type="doi">10.1093/humrep/deaa205</pub-id><pub-id pub-id-type="pmid">33020802</pub-id>
</element-citation></ref><ref id="B17-jdb-13-00017"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Young</surname><given-names>L.E.</given-names></name>
<name><surname>Sinclair</surname><given-names>K.D.</given-names></name>
<name><surname>Wilmut</surname><given-names>I.</given-names></name>
</person-group><article-title>Large offspring syndrome in cattle and sheep</article-title><source>Rev. Reprod.</source><year>1998</year><volume>3</volume><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1530/ror.0.0030155</pub-id><pub-id pub-id-type="pmid">9829550</pub-id>
</element-citation></ref><ref id="B18-jdb-13-00017"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Elhakeem</surname><given-names>A.</given-names></name>
<name><surname>Taylor</surname><given-names>A.E.</given-names></name>
<name><surname>Inskip</surname><given-names>H.M.</given-names></name>
<name><surname>Huang</surname><given-names>J.Y.</given-names></name>
<name><surname>Mansell</surname><given-names>T.</given-names></name>
<name><surname>Rodrigues</surname><given-names>C.</given-names></name>
<name><surname>Asta</surname><given-names>F.</given-names></name>
<name><surname>Blaauwendraad</surname><given-names>S.M.</given-names></name>
<name><surname>H&#x000e5;berg</surname><given-names>S.E.</given-names></name>
<name><surname>Halliday</surname><given-names>J.</given-names></name>
</person-group><article-title>Long-term cardiometabolic health in people born after assisted reproductive technology: A multi-cohort analysis</article-title><source>Eur. Heart J.</source><year>2023</year><volume>44</volume><fpage>1464</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehac726</pub-id><pub-id pub-id-type="pmid">36740401</pub-id>
</element-citation></ref><ref id="B19-jdb-13-00017"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wijs</surname><given-names>L.</given-names></name>
<name><surname>Doherty</surname><given-names>D.</given-names></name>
<name><surname>Keelan</surname><given-names>J.</given-names></name>
<name><surname>Burton</surname><given-names>P.</given-names></name>
<name><surname>Yovich</surname><given-names>J.</given-names></name>
<name><surname>Beilin</surname><given-names>L.</given-names></name>
<name><surname>Mori</surname><given-names>T.</given-names></name>
<name><surname>Huang</surname><given-names>R.</given-names></name>
<name><surname>Adams</surname><given-names>L.</given-names></name>
<name><surname>Olynyk</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort</article-title><source>Hum. Reprod.</source><year>2022</year><volume>37</volume><fpage>1880</fpage><lpage>1895</lpage><pub-id pub-id-type="doi">10.1093/humrep/deac122</pub-id><pub-id pub-id-type="pmid">35640037</pub-id>
</element-citation></ref><ref id="B20-jdb-13-00017"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
<name><surname>Berry</surname><given-names>M.J.</given-names></name>
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>Darby</surname><given-names>J.R.</given-names></name>
<name><surname>Frasch</surname><given-names>M.G.</given-names></name>
<name><surname>Gatford</surname><given-names>K.L.</given-names></name>
<name><surname>Giussani</surname><given-names>D.A.</given-names></name>
<name><surname>Gray</surname><given-names>C.L.</given-names></name>
<name><surname>Harding</surname><given-names>R.</given-names></name>
<name><surname>Herrera</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Improving pregnancy outcomes in humans through studies in sheep</article-title><source>Am. J. Physiol.-Regul. Integr. Comp. Physiol.</source><year>2018</year><volume>315</volume><fpage>R1123</fpage><lpage>R1153</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00391.2017</pub-id><pub-id pub-id-type="pmid">30325659</pub-id>
</element-citation></ref><ref id="B21-jdb-13-00017"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dimasi</surname><given-names>C.G.</given-names></name>
<name><surname>Darby</surname><given-names>J.R.T.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>A change of heart: Understanding the mechanisms regulating cardiac proliferation and metabolism before and after birth</article-title><source>J. Physiol.</source><year>2023</year><volume>601</volume><fpage>1319</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1113/JP284137</pub-id><pub-id pub-id-type="pmid">36872609</pub-id>
</element-citation></ref><ref id="B22-jdb-13-00017"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chattergoon</surname><given-names>N.N.</given-names></name>
<name><surname>Giraud</surname><given-names>G.D.</given-names></name>
<name><surname>Louey</surname><given-names>S.</given-names></name>
<name><surname>Stork</surname><given-names>P.</given-names></name>
<name><surname>Fowden</surname><given-names>A.L.</given-names></name>
<name><surname>Thornburg</surname><given-names>K.L.</given-names></name>
</person-group><article-title>Thyroid hormone drives fetal cardiomyocyte maturation</article-title><source>FASEB J.</source><year>2012</year><volume>26</volume><fpage>397</fpage><pub-id pub-id-type="doi">10.1096/fj.10-179895</pub-id><pub-id pub-id-type="pmid">21974928</pub-id>
</element-citation></ref><ref id="B23-jdb-13-00017"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thornburg</surname><given-names>K.</given-names></name>
<name><surname>Jonker</surname><given-names>S.</given-names></name>
<name><surname>O&#x02019;Tierney</surname><given-names>P.</given-names></name>
<name><surname>Chattergoon</surname><given-names>N.</given-names></name>
<name><surname>Louey</surname><given-names>S.</given-names></name>
<name><surname>Faber</surname><given-names>J.</given-names></name>
<name><surname>Giraud</surname><given-names>G.</given-names></name>
</person-group><article-title>Regulation of the cardiomyocyte population in the developing heart</article-title><source>Prog. Biophys. Mol. Biol.</source><year>2011</year><volume>106</volume><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2010.11.010</pub-id><pub-id pub-id-type="pmid">21147149</pub-id>
</element-citation></ref><ref id="B24-jdb-13-00017"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giraud</surname><given-names>G.D.</given-names></name>
<name><surname>Louey</surname><given-names>S.</given-names></name>
<name><surname>Jonker</surname><given-names>S.</given-names></name>
<name><surname>Schultz</surname><given-names>J.</given-names></name>
<name><surname>Thornburg</surname><given-names>K.L.</given-names></name>
</person-group><article-title>Cortisol Stimulates Cell Cycle Activity in the Cardiomyocyte of the Sheep Fetus</article-title><source>Endocrinology</source><year>2006</year><volume>147</volume><fpage>3643</fpage><lpage>3649</lpage><pub-id pub-id-type="doi">10.1210/en.2006-0061</pub-id><pub-id pub-id-type="pmid">16690807</pub-id>
</element-citation></ref><ref id="B25-jdb-13-00017"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>N.Z.</given-names></name>
<name><surname>Wardell</surname><given-names>S.E.</given-names></name>
<name><surname>Burnstein</surname><given-names>K.L.</given-names></name>
<name><surname>Defranco</surname><given-names>D.</given-names></name>
<name><surname>Fuller</surname><given-names>P.J.</given-names></name>
<name><surname>Giguere</surname><given-names>V.</given-names></name>
<name><surname>Hochberg</surname><given-names>R.B.</given-names></name>
<name><surname>McKay</surname><given-names>L.</given-names></name>
<name><surname>Renoir</surname><given-names>J.-M.</given-names></name>
<name><surname>Weigel</surname><given-names>N.L.</given-names></name>
</person-group><article-title>International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: Glucocorticoid, mineralocorticoid, progesterone, and androgen receptors</article-title><source>Pharmacol. Rev.</source><year>2006</year><volume>58</volume><fpage>782</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1124/pr.58.4.9</pub-id><pub-id pub-id-type="pmid">17132855</pub-id>
</element-citation></ref><ref id="B26-jdb-13-00017"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fowden</surname><given-names>A.L.</given-names></name>
<name><surname>Giussani</surname><given-names>D.A.</given-names></name>
<name><surname>Forhead</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Intrauterine programming of physiological systems: Causes and consequences</article-title><source>Physiology</source><year>2006</year><volume>21</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1152/physiol.00050.2005</pub-id><pub-id pub-id-type="pmid">16443820</pub-id>
</element-citation></ref><ref id="B27-jdb-13-00017"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saif</surname><given-names>Z.</given-names></name>
<name><surname>Hodyl</surname><given-names>N.A.</given-names></name>
<name><surname>Hobbs</surname><given-names>E.</given-names></name>
<name><surname>Tuck</surname><given-names>A.R.</given-names></name>
<name><surname>Butler</surname><given-names>M.S.</given-names></name>
<name><surname>Osei-Kumah</surname><given-names>A.</given-names></name>
<name><surname>Clifton</surname><given-names>V.L.</given-names></name>
</person-group><article-title>The human placenta expresses multiple glucocorticoid receptor isoforms that are altered by fetal sex, growth restriction and maternal asthma</article-title><source>Placenta</source><year>2014</year><volume>35</volume><fpage>260</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2014.01.012</pub-id><pub-id pub-id-type="pmid">24559727</pub-id>
</element-citation></ref><ref id="B28-jdb-13-00017"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clifton</surname><given-names>V.L.</given-names></name>
<name><surname>McDonald</surname><given-names>M.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
<name><surname>Holman</surname><given-names>S.L.</given-names></name>
<name><surname>Lock</surname><given-names>M.C.</given-names></name>
<name><surname>Saif</surname><given-names>Z.</given-names></name>
<name><surname>Meakin</surname><given-names>A.</given-names></name>
<name><surname>Wooldridge</surname><given-names>A.L.</given-names></name>
<name><surname>Gatford</surname><given-names>K.L.</given-names></name>
<name><surname>Wallace</surname><given-names>M.J.</given-names></name>
<etal/>
</person-group><article-title>Placental glucocorticoid receptor isoforms in a sheep model of maternal allergic asthma</article-title><source>Placenta</source><year>2019</year><volume>83</volume><fpage>33</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2019.06.380</pub-id><pub-id pub-id-type="pmid">31477204</pub-id>
</element-citation></ref><ref id="B29-jdb-13-00017"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Orgeig</surname><given-names>S.</given-names></name>
<name><surname>McGillick</surname><given-names>E.V.</given-names></name>
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Increased lung prolyl hydroxylase and decreased glucocorticoid receptor are related to decreased surfactant protein in the growth-restricted sheep fetus</article-title><source>Am. J. Physiol.-Lung Cell. Mol. Physiol.</source><year>2015</year><volume>309</volume><fpage>L84</fpage><lpage>L97</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00275.2014</pub-id><pub-id pub-id-type="pmid">25934670</pub-id>
</element-citation></ref><ref id="B30-jdb-13-00017"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amanollahi</surname><given-names>R.</given-names></name>
<name><surname>Holman</surname><given-names>S.L.</given-names></name>
<name><surname>Bertossa</surname><given-names>M.R.</given-names></name>
<name><surname>Meakin</surname><given-names>A.S.</given-names></name>
<name><surname>Thornburg</surname><given-names>K.L.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Wiese</surname><given-names>M.D.</given-names></name>
<name><surname>Lock</surname><given-names>M.C.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Ontogeny of Fetal Cardiometabolic Pathways: The Potential Role of Cortisol and Thyroid Hormones in Driving the Transition from Preterm to Near-term Heart Development in Sheep</article-title><source>J. Cardiovasc. Dev. Dis.</source><year>2025</year><volume>12</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.3390/jcdd12020036</pub-id><pub-id pub-id-type="pmid">39997470</pub-id>
</element-citation></ref><ref id="B31-jdb-13-00017"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davies</surname><given-names>K.L.</given-names></name>
<name><surname>Camm</surname><given-names>E.J.</given-names></name>
<name><surname>Smith</surname><given-names>D.J.</given-names></name>
<name><surname>Miles</surname><given-names>J.</given-names></name>
<name><surname>Forhead</surname><given-names>A.J.</given-names></name>
<name><surname>Murray</surname><given-names>A.J.</given-names></name>
<name><surname>Fowden</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Developmental programming of mitochondrial substrate metabolism in skeletal muscle of adult sheep by cortisol exposure before birth</article-title><source>J. Dev. Orig. Health Dis.</source><year>2023</year><volume>14</volume><fpage>77</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1017/S204017442200040X</pub-id><pub-id pub-id-type="pmid">35822505</pub-id>
</element-citation></ref><ref id="B32-jdb-13-00017"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>E.</given-names></name>
<name><surname>Ardehali</surname><given-names>H.</given-names></name>
<name><surname>Balaban</surname><given-names>R.S.</given-names></name>
<name><surname>DiLisa</surname><given-names>F.</given-names></name>
<name><surname>Dorn</surname><given-names>G.W.</given-names></name>
<name><surname>Kitsis</surname><given-names>R.N.</given-names></name>
<name><surname>Otsu</surname><given-names>K.</given-names></name>
<name><surname>Ping</surname><given-names>P.</given-names></name>
<name><surname>Rizzuto</surname><given-names>R.</given-names></name>
<name><surname>Sack</surname><given-names>M.N.</given-names></name>
</person-group><article-title>Mitochondrial function, biology, and role in disease: A scientific statement from the American Heart Association</article-title><source>Circ. Res.</source><year>2016</year><volume>118</volume><fpage>1960</fpage><lpage>1991</lpage><pub-id pub-id-type="doi">10.1161/RES.0000000000000104</pub-id><pub-id pub-id-type="pmid">27126807</pub-id>
</element-citation></ref><ref id="B33-jdb-13-00017"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bhullar</surname><given-names>S.K.</given-names></name>
<name><surname>Dhalla</surname><given-names>N.S.</given-names></name>
</person-group><article-title>Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure</article-title><source>Antioxidants</source><year>2023</year><volume>12</volume><elocation-id>1941</elocation-id><pub-id pub-id-type="doi">10.3390/antiox12111941</pub-id><pub-id pub-id-type="pmid">38001794</pub-id>
</element-citation></ref><ref id="B34-jdb-13-00017"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shao</surname><given-names>D.</given-names></name>
<name><surname>Tian</surname><given-names>R.</given-names></name>
</person-group><article-title>Glucose transporters in cardiac metabolism and hypertrophy</article-title><source>Compr. Physiol.</source><year>2015</year><volume>6</volume><fpage>331</fpage><pub-id pub-id-type="doi">10.1002/j.2040-4603.2016.tb00680.x</pub-id><pub-id pub-id-type="pmid">26756635</pub-id>
</element-citation></ref><ref id="B35-jdb-13-00017"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dimasi</surname><given-names>C.G.</given-names></name>
<name><surname>Darby</surname><given-names>J.R.T.</given-names></name>
<name><surname>Cho</surname><given-names>S.K.S.</given-names></name>
<name><surname>Saini</surname><given-names>B.S.</given-names></name>
<name><surname>Holman</surname><given-names>S.L.</given-names></name>
<name><surname>Meakin</surname><given-names>A.S.</given-names></name>
<name><surname>Wiese</surname><given-names>M.D.</given-names></name>
<name><surname>Macgowan</surname><given-names>C.K.</given-names></name>
<name><surname>Seed</surname><given-names>M.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Reduced in utero substrate supply decreases mitochondrial abundance and alters the expression of metabolic signalling molecules in the fetal sheep heart</article-title><source>J. Physiol.</source><year>2024</year><volume>602</volume><fpage>5901</fpage><lpage>5922</lpage><pub-id pub-id-type="doi">10.1113/JP285572</pub-id><pub-id pub-id-type="pmid">37996982</pub-id>
</element-citation></ref><ref id="B36-jdb-13-00017"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>MacLennan</surname><given-names>D.H.</given-names></name>
<name><surname>Kranias</surname><given-names>E.G.</given-names></name>
</person-group><article-title>Phospholamban: A crucial regulator of cardiac contractility</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2003</year><volume>4</volume><fpage>566</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1038/nrm1151</pub-id><pub-id pub-id-type="pmid">12838339</pub-id>
</element-citation></ref><ref id="B37-jdb-13-00017"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seckl</surname><given-names>J.R.</given-names></name>
<name><surname>Holmes</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Mechanisms of disease: Glucocorticoids, their placental metabolism and fetal &#x02018;programming&#x02019; of adult pathophysiology</article-title><source>Nat. Clin. Pract. Endocrinol. Metab.</source><year>2007</year><volume>3</volume><fpage>479</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1038/ncpendmet0515</pub-id><pub-id pub-id-type="pmid">17515892</pub-id>
</element-citation></ref><ref id="B38-jdb-13-00017"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dancause</surname><given-names>K.N.</given-names></name>
<name><surname>Veru</surname><given-names>F.</given-names></name>
<name><surname>Andersen</surname><given-names>R.E.</given-names></name>
<name><surname>Laplante</surname><given-names>D.P.</given-names></name>
<name><surname>King</surname><given-names>S.</given-names></name>
</person-group><article-title>Prenatal stress due to a natural disaster predicts insulin secretion in adolescence</article-title><source>Early Hum. Dev.</source><year>2013</year><volume>89</volume><fpage>773</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1016/j.earlhumdev.2013.06.006</pub-id><pub-id pub-id-type="pmid">23830724</pub-id>
</element-citation></ref><ref id="B39-jdb-13-00017"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barnes</surname><given-names>J.</given-names></name>
<name><surname>Sutcliffe</surname><given-names>A.</given-names></name>
<name><surname>Kristoffersen</surname><given-names>I.</given-names></name>
<name><surname>Loft</surname><given-names>A.</given-names></name>
<name><surname>Wennerholm</surname><given-names>U.</given-names></name>
<name><surname>Tarlatzis</surname><given-names>B.</given-names></name>
<name><surname>Kantaris</surname><given-names>X.</given-names></name>
<name><surname>Nekkebroeck</surname><given-names>J.</given-names></name>
<name><surname>Hagberg</surname><given-names>B.</given-names></name>
<name><surname>Madsen</surname><given-names>S.</given-names></name>
</person-group><article-title>The influence of assisted reproduction on family functioning and children&#x02019;s socio-emotional development: Results from a European study</article-title><source>Hum. Reprod.</source><year>2004</year><volume>19</volume><fpage>1480</fpage><lpage>1487</lpage><pub-id pub-id-type="doi">10.1093/humrep/deh239</pub-id><pub-id pub-id-type="pmid">15105405</pub-id>
</element-citation></ref><ref id="B40-jdb-13-00017"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grundy</surname><given-names>D.</given-names></name>
</person-group><article-title>Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology</article-title><source>J. Physiol.</source><year>2015</year><volume>593</volume><fpage>2547</fpage><lpage>2549</lpage><pub-id pub-id-type="doi">10.1113/JP270818</pub-id><pub-id pub-id-type="pmid">26095019</pub-id>
</element-citation></ref><ref id="B41-jdb-13-00017"><label>41.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Russell</surname><given-names>W.M.S.</given-names></name>
<name><surname>Burch</surname><given-names>R.L.</given-names></name>
</person-group><source>The Principles of Humane Experimental Technique</source><publisher-name>Universities Federation of Animal Welfare</publisher-name><publisher-loc>Wheathampstead, UK</publisher-loc><year>1959</year></element-citation></ref><ref id="B42-jdb-13-00017"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Percie du Sert</surname><given-names>N.</given-names></name>
<name><surname>Hurst</surname><given-names>V.</given-names></name>
<name><surname>Ahluwalia</surname><given-names>A.</given-names></name>
<name><surname>Alam</surname><given-names>S.</given-names></name>
<name><surname>Avey</surname><given-names>M.T.</given-names></name>
<name><surname>Baker</surname><given-names>M.</given-names></name>
<name><surname>Browne</surname><given-names>W.J.</given-names></name>
<name><surname>Clark</surname><given-names>A.</given-names></name>
<name><surname>Cuthill</surname><given-names>I.C.</given-names></name>
<name><surname>Dirnagl</surname><given-names>U.</given-names></name>
<etal/>
</person-group><article-title>The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research</article-title><source>Br. J. Pharmacol</source><year>2020</year><volume>177</volume><fpage>3617</fpage><lpage>3624</lpage><pub-id pub-id-type="doi">10.1111/bph.15193</pub-id><pub-id pub-id-type="pmid">32662519</pub-id>
</element-citation></ref><ref id="B43-jdb-13-00017"><label>43.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>AFRC</collab>
</person-group><article-title>Energy and protein requirements of ruminants</article-title><source>An Advisory Manual Prepared by the AFRC Technical Committee on Responses to Nutrients</source><publisher-name>CAB International</publisher-name><publisher-loc>Wallingford, UK</publisher-loc><year>1993</year></element-citation></ref><ref id="B44-jdb-13-00017"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Smith</surname><given-names>D.</given-names></name>
<name><surname>Seamark</surname><given-names>R.</given-names></name>
</person-group><article-title>Timing of multiple ovulations in the ewe after treatment with FSH or PMSG with and without GnRH</article-title><source>Reproduction</source><year>1986</year><volume>77</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1530/jrf.0.0770135</pub-id></element-citation></ref><ref id="B45-jdb-13-00017"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Holm</surname><given-names>P.</given-names></name>
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Seamark</surname><given-names>R.</given-names></name>
</person-group><article-title>Embryo viability, duration of gestation and birth weight in sheep after transfer of in vitro matured and in vitro fertilized zygotes cultured in vitro or in vivo</article-title><source>Reproduction</source><year>1996</year><volume>107</volume><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1530/jrf.0.1070175</pub-id><pub-id pub-id-type="pmid">8882282</pub-id>
</element-citation></ref><ref id="B46-jdb-13-00017"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kakar</surname><given-names>M.</given-names></name>
<name><surname>Maddocks</surname><given-names>S.</given-names></name>
<name><surname>Lorimer</surname><given-names>M.</given-names></name>
<name><surname>Kleemann</surname><given-names>D.</given-names></name>
<name><surname>Rudiger</surname><given-names>S.</given-names></name>
<name><surname>Hartwich</surname><given-names>K.</given-names></name>
<name><surname>Walker</surname><given-names>S.</given-names></name>
</person-group><article-title>The effect of peri-conception nutrition on embryo quality in the superovulated ewe</article-title><source>Theriogenology</source><year>2005</year><volume>64</volume><fpage>1090</fpage><lpage>1103</lpage><pub-id pub-id-type="doi">10.1016/j.theriogenology.2004.12.017</pub-id><pub-id pub-id-type="pmid">16125553</pub-id>
</element-citation></ref><ref id="B47-jdb-13-00017"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleemann</surname><given-names>D.</given-names></name>
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Seamark</surname><given-names>R.</given-names></name>
</person-group><article-title>Enhanced fetal growth in sheep administered progesterone during the first three days of pregnancy</article-title><source>Reproduction</source><year>1994</year><volume>102</volume><fpage>411</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1530/jrf.0.1020411</pub-id></element-citation></ref><ref id="B48-jdb-13-00017"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Hill</surname><given-names>J.</given-names></name>
<name><surname>Kleemann</surname><given-names>D.</given-names></name>
<name><surname>Nancarrow</surname><given-names>C.</given-names></name>
</person-group><article-title>Development of ovine embryos in synthetic oviductal fluid containing amino acids at oviductal fluid concentrations</article-title><source>Biol. Reprod.</source><year>1996</year><volume>55</volume><fpage>703</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1095/biolreprod55.3.703</pub-id><pub-id pub-id-type="pmid">8862790</pub-id>
</element-citation></ref><ref id="B49-jdb-13-00017"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleemann</surname><given-names>D.</given-names></name>
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Hartwich</surname><given-names>K.</given-names></name>
<name><surname>Fong</surname><given-names>L.</given-names></name>
<name><surname>Seamark</surname><given-names>R.</given-names></name>
<name><surname>Robinson</surname><given-names>J.</given-names></name>
<name><surname>Owens</surname><given-names>J.</given-names></name>
</person-group><article-title>Fetoplacental growth in sheep administered progesterone during the first three days of pregnancy</article-title><source>Placenta</source><year>2001</year><volume>22</volume><fpage>14</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1053/plac.2000.0594</pub-id><pub-id pub-id-type="pmid">11162348</pub-id>
</element-citation></ref><ref id="B50-jdb-13-00017"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Heard</surname><given-names>T.</given-names></name>
<name><surname>Seamark</surname><given-names>R.</given-names></name>
</person-group><article-title>In vitro culture of sheep embryos without co-culture: Successes and perspectives</article-title><source>Theriogenology</source><year>1992</year><volume>37</volume><fpage>111</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/0093-691X(92)90250-U</pub-id></element-citation></ref><ref id="B51-jdb-13-00017"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>K.C.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>Duffield</surname><given-names>J.A.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Suter</surname><given-names>C.M.</given-names></name>
<name><surname>Brooks</surname><given-names>D.A.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb</article-title><source>J. Physiol.</source><year>2011</year><volume>589</volume><fpage>4709</fpage><lpage>4722</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2011.211185</pub-id><pub-id pub-id-type="pmid">21807611</pub-id>
</element-citation></ref><ref id="B52-jdb-13-00017"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bustin</surname><given-names>S.A.</given-names></name>
<name><surname>Benes</surname><given-names>V.</given-names></name>
<name><surname>Garson</surname><given-names>J.A.</given-names></name>
<name><surname>Hellemans</surname><given-names>J.</given-names></name>
<name><surname>Huggett</surname><given-names>J.</given-names></name>
<name><surname>Kubista</surname><given-names>M.</given-names></name>
<name><surname>Mueller</surname><given-names>R.</given-names></name>
<name><surname>Nolan</surname><given-names>T.</given-names></name>
<name><surname>Pfaffl</surname><given-names>M.W.</given-names></name>
<name><surname>Shipley</surname><given-names>G.L.</given-names></name>
</person-group><article-title>The MIQE Guidelines: M inimum I nformation for Publication of Q uantitative Real-Time PCR E xperiments</article-title><source>Clin Chem.</source><year>2009</year><volume>55</volume><fpage>611</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2008.112797</pub-id><pub-id pub-id-type="pmid">19246619</pub-id>
</element-citation></ref><ref id="B53-jdb-13-00017"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>K.C.</given-names></name>
<name><surname>Lim</surname><given-names>C.H.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Duffield</surname><given-names>J.A.</given-names></name>
<name><surname>Brooks</surname><given-names>D.A.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Alteration of cardiac glucose metabolism in association to low birth weight: Experimental evidence in lambs with left ventricular hypertrophy</article-title><source>Metabolism</source><year>2013</year><volume>62</volume><fpage>1662</fpage><lpage>1672</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2013.06.013</pub-id><pub-id pub-id-type="pmid">23928106</pub-id>
</element-citation></ref><ref id="B54-jdb-13-00017"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Forbes</surname><given-names>H.</given-names></name>
<name><surname>Nyengaard</surname><given-names>J.R.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Chronic hypoxemia in late gestation decreases cardiomyocyte number but does not change expression of hypoxia-responsive genes</article-title><source>J. Am. Heart Assoc.</source><year>2014</year><volume>3</volume><fpage>e000531</fpage><pub-id pub-id-type="doi">10.1161/JAHA.113.000531</pub-id><pub-id pub-id-type="pmid">25085511</pub-id>
</element-citation></ref><ref id="B55-jdb-13-00017"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vandesompele</surname><given-names>J.</given-names></name>
<name><surname>De Preter</surname><given-names>K.</given-names></name>
<name><surname>Pattyn</surname><given-names>F.</given-names></name>
<name><surname>Poppe</surname><given-names>B.</given-names></name>
<name><surname>Van Roy</surname><given-names>N.</given-names></name>
<name><surname>De Paepe</surname><given-names>A.</given-names></name>
<name><surname>Speleman</surname><given-names>F.</given-names></name>
</person-group><article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</article-title><source>Genome Biol.</source><year>2002</year><volume>3</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1186/gb-2002-3-7-research0034</pub-id><pub-id pub-id-type="pmid">12184808</pub-id>
</element-citation></ref><ref id="B56-jdb-13-00017"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McGillick</surname><given-names>E.V.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Orgeig</surname><given-names>S.</given-names></name>
</person-group><article-title>Intrafetal glucose infusion alters glucocorticoid signaling and reduces surfactant protein mRNA expression in the lung of the late-gestation sheep fetus</article-title><source>Am. J. Physiol.-Regul. Integr. Comp. Physiol.</source><year>2014</year><volume>307</volume><fpage>R538</fpage><lpage>R545</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00053.2014</pub-id><pub-id pub-id-type="pmid">24990855</pub-id>
</element-citation></ref><ref id="B57-jdb-13-00017"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lie</surname><given-names>S.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
<name><surname>Williams-Wyss</surname><given-names>O.</given-names></name>
<name><surname>Ozanne</surname><given-names>S.E.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Walker</surname><given-names>S.K.</given-names></name>
<name><surname>Kleemann</surname><given-names>D.O.</given-names></name>
<name><surname>MacLaughlin</surname><given-names>S.M.</given-names></name>
<name><surname>Roberts</surname><given-names>C.T.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
</person-group><article-title>Impact of embryo number and periconceptional undernutrition on factors regulating adipogenesis, lipogenesis, and metabolism in adipose tissuein the sheep fetus</article-title><source>Am. J. Physiol.-Endocrinol. Metab.</source><year>2013</year><volume>305</volume><fpage>E931</fpage><lpage>E941</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00180.2013</pub-id><pub-id pub-id-type="pmid">23921136</pub-id>
</element-citation></ref><ref id="B58-jdb-13-00017"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lie</surname><given-names>S.</given-names></name>
<name><surname>Sim</surname><given-names>S.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Williams-Wyss</surname><given-names>O.</given-names></name>
<name><surname>MacLaughlin</surname><given-names>S.</given-names></name>
<name><surname>Kleemann</surname><given-names>D.</given-names></name>
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Roberts</surname><given-names>C.T.</given-names></name>
<name><surname>Morrison</surname><given-names>J.</given-names></name>
</person-group><article-title>Maternal undernutrition around the time of conception and embryo number each impact on the abundance of key regulators of cardiac growth and metabolism in the fetal sheep heart</article-title><source>J. Dev. Orig. Health Dis.</source><year>2013</year><volume>4</volume><fpage>377</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1017/S2040174413000354</pub-id><pub-id pub-id-type="pmid">24970731</pub-id>
</element-citation></ref><ref id="B59-jdb-13-00017"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soo</surname><given-names>P.S.</given-names></name>
<name><surname>Hiscock</surname><given-names>J.</given-names></name>
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>Roberts</surname><given-names>C.T.</given-names></name>
<name><surname>Davey</surname><given-names>A.K.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Maternal undernutrition reduces P-glycoprotein in guinea pig placenta and developing brain in late gestation</article-title><source>Reprod. Toxicol.</source><year>2012</year><volume>33</volume><fpage>374</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.reprotox.2012.01.013</pub-id><pub-id pub-id-type="pmid">22326852</pub-id>
</element-citation></ref><ref id="B60-jdb-13-00017"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hellemans</surname><given-names>J.</given-names></name>
<name><surname>Mortier</surname><given-names>G.</given-names></name>
<name><surname>De Paepe</surname><given-names>A.</given-names></name>
<name><surname>Speleman</surname><given-names>F.</given-names></name>
<name><surname>Vandesompele</surname><given-names>J.</given-names></name>
</person-group><article-title>qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data</article-title><source>Genome Biol.</source><year>2007</year><volume>8</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/gb-2007-8-2-r19</pub-id></element-citation></ref><ref id="B61-jdb-13-00017"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nicholas</surname><given-names>L.M.</given-names></name>
<name><surname>Rattanatray</surname><given-names>L.</given-names></name>
<name><surname>MacLaughlin</surname><given-names>S.M.</given-names></name>
<name><surname>Ozanne</surname><given-names>S.E.</given-names></name>
<name><surname>Kleemann</surname><given-names>D.O.</given-names></name>
<name><surname>Walker</surname><given-names>S.K.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Muhlh&#x000e4;usler</surname><given-names>B.S.</given-names></name>
<name><surname>Martin-Gronert</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring</article-title><source>FASEB J.</source><year>2013</year><volume>27</volume><fpage>3786</fpage><lpage>3796</lpage><pub-id pub-id-type="doi">10.1096/fj.13-227918</pub-id><pub-id pub-id-type="pmid">23729590</pub-id>
</element-citation></ref><ref id="B62-jdb-13-00017"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darby</surname><given-names>J.R.</given-names></name>
<name><surname>Sorvina</surname><given-names>A.</given-names></name>
<name><surname>Bader</surname><given-names>C.A.</given-names></name>
<name><surname>Lock</surname><given-names>M.C.</given-names></name>
<name><surname>Soo</surname><given-names>J.Y.</given-names></name>
<name><surname>Holman</surname><given-names>S.L.</given-names></name>
<name><surname>Seed</surname><given-names>M.</given-names></name>
<name><surname>Kuchel</surname><given-names>T.</given-names></name>
<name><surname>Brooks</surname><given-names>D.A.</given-names></name>
<name><surname>Plush</surname><given-names>S.E.</given-names></name>
</person-group><article-title>Detecting metabolic differences in fetal and adult sheep adipose and skeletal muscle tissues</article-title><source>J. Biophotonics</source><year>2020</year><volume>13</volume><elocation-id>e201960085</elocation-id><pub-id pub-id-type="doi">10.1002/jbio.201960085</pub-id><pub-id pub-id-type="pmid">31793184</pub-id>
</element-citation></ref><ref id="B63-jdb-13-00017"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darby</surname><given-names>J.R.</given-names></name>
<name><surname>Chiu</surname><given-names>J.</given-names></name>
<name><surname>Regnault</surname><given-names>T.R.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Placental insufficiency induces a sexually dimorphic response in the expression of cardiac growth and metabolic signalling molecules upon exposure to a postnatal western diet in guinea pigs</article-title><source>J. Dev. Orig. Health Dis.</source><year>2022</year><volume>13</volume><fpage>345</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1017/S204017442100043X</pub-id><pub-id pub-id-type="pmid">34308829</pub-id>
</element-citation></ref><ref id="B64-jdb-13-00017"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>Loke</surname><given-names>X.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Andersen</surname><given-names>J.B.</given-names></name>
<name><surname>Nyengaard</surname><given-names>J.R.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>IUGR decreases cardiomyocyte endowment and alters cardiac metabolism in a sex-and cause-of-IUGR-specific manner</article-title><source>Am. J. Physiol.-Regul. Integr. Comp. Physiol.</source><year>2018</year><volume>315</volume><fpage>R48</fpage><lpage>R67</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00180.2017</pub-id><pub-id pub-id-type="pmid">29561647</pub-id>
</element-citation></ref><ref id="B65-jdb-13-00017"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lie</surname><given-names>S.</given-names></name>
<name><surname>Hui</surname><given-names>M.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Muhlhausler</surname><given-names>B.S.</given-names></name>
<name><surname>Posterino</surname><given-names>G.S.</given-names></name>
<name><surname>Dunn</surname><given-names>S.L.</given-names></name>
<name><surname>Wang</surname><given-names>K.C.</given-names></name>
<name><surname>Botting</surname><given-names>K.J.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Exposure to rosiglitazone, a PPAR-&#x003b3; agonist, in late gestation reduces the abundance of factors regulating cardiac metabolism and cardiomyocyte size in the sheep fetus</article-title><source>Am. J. Physiol.-Regul. Integr. Comp. Physiol.</source><year>2014</year><volume>306</volume><fpage>R429</fpage><lpage>R437</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00431.2013</pub-id><pub-id pub-id-type="pmid">24477540</pub-id>
</element-citation></ref><ref id="B66-jdb-13-00017"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>K.C.</given-names></name>
<name><surname>Tosh</surname><given-names>D.N.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>McMillen</surname><given-names>I.C.</given-names></name>
<name><surname>Duffield</surname><given-names>J.A.</given-names></name>
<name><surname>Brooks</surname><given-names>D.A.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>IGF-2R-G&#x003b1;q signaling and cardiac hypertrophy in the low-birth-weight lamb</article-title><source>Am. J. Physiol.-Regul. Integr. Comp. Physiol.</source><year>2015</year><volume>308</volume><fpage>R627</fpage><lpage>R635</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00346.2014</pub-id><pub-id pub-id-type="pmid">25632020</pub-id>
</element-citation></ref><ref id="B67-jdb-13-00017"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darby</surname><given-names>J.R.T.</given-names></name>
<name><surname>Saini</surname><given-names>B.S.</given-names></name>
<name><surname>Soo</surname><given-names>J.Y.</given-names></name>
<name><surname>Lock</surname><given-names>M.C.</given-names></name>
<name><surname>Holman</surname><given-names>S.L.</given-names></name>
<name><surname>Bradshaw</surname><given-names>E.L.</given-names></name>
<name><surname>McInnes</surname><given-names>S.J.P.</given-names></name>
<name><surname>Voelcker</surname><given-names>N.H.</given-names></name>
<name><surname>Macgowan</surname><given-names>C.K.</given-names></name>
<name><surname>Seed</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth</article-title><source>J. Physiol.</source><year>2019</year><volume>597</volume><fpage>5063</fpage><lpage>5077</lpage><pub-id pub-id-type="doi">10.1113/JP278110</pub-id><pub-id pub-id-type="pmid">31483497</pub-id>
</element-citation></ref><ref id="B68-jdb-13-00017"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>G.M.</given-names></name>
<name><surname>Meakin</surname><given-names>A.S.</given-names></name>
<name><surname>Soo</surname><given-names>J.Y.</given-names></name>
<name><surname>Darby</surname><given-names>J.R.</given-names></name>
<name><surname>Varcoe</surname><given-names>T.J.</given-names></name>
<name><surname>Bradshaw</surname><given-names>E.L.</given-names></name>
<name><surname>Lock</surname><given-names>M.C.</given-names></name>
<name><surname>Holman</surname><given-names>S.L.</given-names></name>
<name><surname>Saini</surname><given-names>B.S.</given-names></name>
<name><surname>Macgowan</surname><given-names>C.K.</given-names></name>
</person-group><article-title>Intrauterine growth restriction alters the activity of drug metabolising enzymes in the maternal-placental-fetal unit</article-title><source>Life Sci.</source><year>2021</year><volume>285</volume><fpage>120016</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2021.120016</pub-id><pub-id pub-id-type="pmid">34614415</pub-id>
</element-citation></ref><ref id="B69-jdb-13-00017"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meakin</surname><given-names>A.S.</given-names></name>
<name><surname>Nathanielsz</surname><given-names>P.W.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Huber</surname><given-names>H.F.</given-names></name>
<name><surname>Clifton</surname><given-names>V.L.</given-names></name>
<name><surname>Wiese</surname><given-names>M.D.</given-names></name>
<name><surname>Morrison</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Maternal obesogenic diet during pregnancy and its impact on fetal hepatic function in baboons</article-title><source>Obesity</source><year>2024</year><volume>32</volume><fpage>1910</fpage><lpage>1922</lpage><pub-id pub-id-type="doi">10.1002/oby.24124</pub-id><pub-id pub-id-type="pmid">39210592</pub-id>
</element-citation></ref><ref id="B70-jdb-13-00017"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lock</surname><given-names>M.C.</given-names></name>
<name><surname>Darby</surname><given-names>J.R.T.</given-names></name>
<name><surname>Soo</surname><given-names>J.Y.</given-names></name>
<name><surname>Brooks</surname><given-names>D.A.</given-names></name>
<name><surname>Perumal</surname><given-names>S.R.</given-names></name>
<name><surname>Selvanayagam</surname><given-names>J.B.</given-names></name>
<name><surname>Seed</surname><given-names>M.</given-names></name>
<name><surname>Macgowan</surname><given-names>C.K.</given-names></name>
<name><surname>Porrello</surname><given-names>E.R.</given-names></name>
<name><surname>Tellam</surname><given-names>R.L.</given-names></name>
<etal/>
</person-group><article-title>Differential Response to Injury in Fetal and Adolescent Sheep Hearts in the Immediate Post-myocardial Infarction Period</article-title><source>Front. Physiol.</source><year>2019</year><volume>10</volume><elocation-id>208</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2019.00208</pub-id><pub-id pub-id-type="pmid">30890961</pub-id>
</element-citation></ref><ref id="B71-jdb-13-00017"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roy</surname><given-names>B.N.</given-names></name>
<name><surname>Reid</surname><given-names>R.L.</given-names></name>
<name><surname>Van Vugt</surname><given-names>D.A.</given-names></name>
</person-group><article-title>The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey</article-title><source>Endocrinology</source><year>1999</year><volume>140</volume><fpage>2191</fpage><lpage>2198</lpage><pub-id pub-id-type="doi">10.1210/endo.140.5.6684</pub-id><pub-id pub-id-type="pmid">10218971</pub-id>
</element-citation></ref><ref id="B72-jdb-13-00017"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qureshi</surname><given-names>A.C.</given-names></name>
<name><surname>Bahri</surname><given-names>A.</given-names></name>
<name><surname>Breen</surname><given-names>L.A.</given-names></name>
<name><surname>Barnes</surname><given-names>S.C.</given-names></name>
<name><surname>Powrie</surname><given-names>J.K.</given-names></name>
<name><surname>Thomas</surname><given-names>S.M.</given-names></name>
<name><surname>Carroll</surname><given-names>P.V.</given-names></name>
</person-group><article-title>The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol</article-title><source>Clin. Endocrinol.</source><year>2007</year><volume>66</volume><fpage>632</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2007.02784.x</pub-id></element-citation></ref><ref id="B73-jdb-13-00017"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bohler Jr</surname><given-names>H.C.</given-names></name>
<name><surname>Zoeller</surname><given-names>R.T.</given-names></name>
<name><surname>King</surname><given-names>J.C.</given-names></name>
<name><surname>Rubin</surname><given-names>B.S.</given-names></name>
<name><surname>Weber</surname><given-names>R.</given-names></name>
<name><surname>Merriam</surname><given-names>G.R.</given-names></name>
</person-group><article-title>Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular paraventricular nuclei of the female rat</article-title><source>Mol. Brain Res.</source><year>1990</year><volume>8</volume><fpage>259</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/0169-328X(90)90025-9</pub-id><pub-id pub-id-type="pmid">2170804</pub-id>
</element-citation></ref><ref id="B74-jdb-13-00017"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burgess</surname><given-names>L.H.</given-names></name>
<name><surname>Handa</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats</article-title><source>Endocrinology</source><year>1992</year><volume>131</volume><fpage>1261</fpage><lpage>1269</lpage><pub-id pub-id-type="doi">10.1210/endo.131.3.1324155</pub-id><pub-id pub-id-type="pmid">1324155</pub-id>
</element-citation></ref><ref id="B75-jdb-13-00017"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chrousos</surname><given-names>G.P.</given-names></name>
<name><surname>Torpy</surname><given-names>D.J.</given-names></name>
<name><surname>Gold</surname><given-names>P.W.</given-names></name>
</person-group><article-title>Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications</article-title><source>Ann. Intern. Med.</source><year>1998</year><volume>129</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-129-3-199808010-00012</pub-id><pub-id pub-id-type="pmid">9696732</pub-id>
</element-citation></ref><ref id="B76-jdb-13-00017"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbiydzenyuy</surname><given-names>N.E.</given-names></name>
<name><surname>Qulu</surname><given-names>L.-A.</given-names></name>
</person-group><article-title>Stress, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, and aggression</article-title><source>Metab. Brain Dis.</source><year>2024</year><volume>39</volume><fpage>1613</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1007/s11011-024-01393-w</pub-id><pub-id pub-id-type="pmid">39083184</pub-id>
</element-citation></ref><ref id="B77-jdb-13-00017"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rubinow</surname><given-names>D.R.</given-names></name>
<name><surname>Roca</surname><given-names>C.A.</given-names></name>
<name><surname>Schmidt</surname><given-names>P.J.</given-names></name>
<name><surname>Danaceau</surname><given-names>M.A.</given-names></name>
<name><surname>Putnam</surname><given-names>K.</given-names></name>
<name><surname>Cizza</surname><given-names>G.</given-names></name>
<name><surname>Chrousos</surname><given-names>G.</given-names></name>
<name><surname>Nieman</surname><given-names>L.</given-names></name>
</person-group><article-title>Testosterone Suppression of CRH-Stimulated Cortisol in Men</article-title><source>Neuropsychopharmacology</source><year>2005</year><volume>30</volume><fpage>1906</fpage><lpage>1912</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1300742</pub-id><pub-id pub-id-type="pmid">15841103</pub-id>
</element-citation></ref><ref id="B78-jdb-13-00017"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>N.Z.</given-names></name>
<name><surname>Cidlowski</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Glucocorticoid receptor isoforms generate transcription specificity</article-title><source>Trends Cell Biol.</source><year>2006</year><volume>16</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2006.04.005</pub-id><pub-id pub-id-type="pmid">16697199</pub-id>
</element-citation></ref><ref id="B79-jdb-13-00017"><label>79.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Caramori</surname><given-names>G.</given-names></name>
<name><surname>Mumby</surname><given-names>S.</given-names></name>
<name><surname>Girbino</surname><given-names>G.</given-names></name>
<name><surname>Chung</surname><given-names>K.F.</given-names></name>
<name><surname>Adcock</surname><given-names>I.M.</given-names></name>
</person-group><article-title>Corticosteroids</article-title><source>Nijkamp and Parnham&#x02019;s Principles of Immunopharmacology</source><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2019</year><fpage>661</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-10811-3_32</pub-id></element-citation></ref><ref id="B80-jdb-13-00017"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oakley</surname><given-names>R.H.</given-names></name>
<name><surname>Cidlowski</surname><given-names>J.A.</given-names></name>
</person-group><article-title>The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease</article-title><source>J. Allergy Clin. Immunol.</source><year>2013</year><volume>132</volume><fpage>1033</fpage><lpage>1044</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2013.09.007</pub-id><pub-id pub-id-type="pmid">24084075</pub-id>
</element-citation></ref><ref id="B81-jdb-13-00017"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>N.Z.</given-names></name>
<name><surname>Collins</surname><given-names>J.B.</given-names></name>
<name><surname>Grissom</surname><given-names>S.F.</given-names></name>
<name><surname>Cidlowski</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor</article-title><source>Mol. Cell. Biol.</source><year>2007</year><volume>27</volume><fpage>7143</fpage><lpage>7160</lpage><pub-id pub-id-type="doi">10.1128/MCB.00253-07</pub-id><pub-id pub-id-type="pmid">17682054</pub-id>
</element-citation></ref><ref id="B82-jdb-13-00017"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>N.Z.</given-names></name>
<name><surname>Cidlowski</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes</article-title><source>Mol. Cell</source><year>2005</year><volume>18</volume><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.03.025</pub-id><pub-id pub-id-type="pmid">15866175</pub-id>
</element-citation></ref><ref id="B83-jdb-13-00017"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nehm&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Lobenhofer</surname><given-names>E.K.</given-names></name>
<name><surname>Stamer</surname><given-names>W.D.</given-names></name>
<name><surname>Edelman</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells</article-title><source>BMC Med. Genom.</source><year>2009</year><volume>2</volume><elocation-id>58</elocation-id><pub-id pub-id-type="doi">10.1186/1755-8794-2-58</pub-id></element-citation></ref><ref id="B84-jdb-13-00017"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Galluzzi</surname><given-names>L.</given-names></name>
<name><surname>Kepp</surname><given-names>O.</given-names></name>
<name><surname>Trojel-Hansen</surname><given-names>C.</given-names></name>
<name><surname>Kroemer</surname><given-names>G.</given-names></name>
</person-group><article-title>Mitochondrial control of cellular life, stress, and death</article-title><source>Circ. Res.</source><year>2012</year><volume>111</volume><fpage>1198</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.268946</pub-id><pub-id pub-id-type="pmid">23065343</pub-id>
</element-citation></ref><ref id="B85-jdb-13-00017"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopez-Crisosto</surname><given-names>C.</given-names></name>
<name><surname>Pennanen</surname><given-names>C.</given-names></name>
<name><surname>Vasquez-Trincado</surname><given-names>C.</given-names></name>
<name><surname>Morales</surname><given-names>P.E.</given-names></name>
<name><surname>Bravo-Sagua</surname><given-names>R.</given-names></name>
<name><surname>Quest</surname><given-names>A.F.</given-names></name>
<name><surname>Chiong</surname><given-names>M.</given-names></name>
<name><surname>Lavandero</surname><given-names>S.</given-names></name>
</person-group><article-title>Sarcoplasmic reticulum&#x02013;mitochondria communication in cardiovascular pathophysiology</article-title><source>Nat. Rev. Cardiol.</source><year>2017</year><volume>14</volume><fpage>342</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2017.23</pub-id><pub-id pub-id-type="pmid">28275246</pub-id>
</element-citation></ref><ref id="B86-jdb-13-00017"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Delbridge</surname><given-names>L.M.</given-names></name>
<name><surname>Mellor</surname><given-names>K.M.</given-names></name>
<name><surname>Taylor</surname><given-names>D.J.</given-names></name>
<name><surname>Gottlieb</surname><given-names>R.A.</given-names></name>
</person-group><article-title>Myocardial stress and autophagy: Mechanisms and potential therapies</article-title><source>Nat. Rev. Cardiol.</source><year>2017</year><volume>14</volume><fpage>412</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2017.35</pub-id><pub-id pub-id-type="pmid">28361977</pub-id>
</element-citation></ref><ref id="B87-jdb-13-00017"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giorgi</surname><given-names>C.</given-names></name>
<name><surname>Marchi</surname><given-names>S.</given-names></name>
<name><surname>Pinton</surname><given-names>P.</given-names></name>
</person-group><article-title>The machineries, regulation and cellular functions of mitochondrial calcium</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2018</year><volume>19</volume><fpage>713</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0052-8</pub-id><pub-id pub-id-type="pmid">30143745</pub-id>
</element-citation></ref><ref id="B88-jdb-13-00017"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fern&#x000e1;ndez-Vizarra</surname><given-names>E.</given-names></name>
<name><surname>Enr&#x000ed;quez</surname><given-names>J.A.</given-names></name>
<name><surname>P&#x000e9;rez-Martos</surname><given-names>A.</given-names></name>
<name><surname>Montoya</surname><given-names>J.</given-names></name>
<name><surname>Fern&#x000e1;ndez-Silva</surname><given-names>P.</given-names></name>
</person-group><article-title>Tissue-specific differences in mitochondrial activity and biogenesis</article-title><source>Mitochondrion</source><year>2011</year><volume>11</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2010.09.011</pub-id><pub-id pub-id-type="pmid">20933104</pub-id>
</element-citation></ref><ref id="B89-jdb-13-00017"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>B.</given-names></name>
<name><surname>Tian</surname><given-names>R.</given-names></name>
</person-group><article-title>Mitochondrial dysfunction in pathophysiology of heart failure</article-title><source>J. Clin. Investig.</source><year>2018</year><volume>128</volume><fpage>3716</fpage><lpage>3726</lpage><pub-id pub-id-type="doi">10.1172/JCI120849</pub-id><pub-id pub-id-type="pmid">30124471</pub-id>
</element-citation></ref><ref id="B90-jdb-13-00017"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borghetti</surname><given-names>G.</given-names></name>
<name><surname>Von Lewinski</surname><given-names>D.</given-names></name>
<name><surname>Eaton</surname><given-names>D.M.</given-names></name>
<name><surname>Sourij</surname><given-names>H.</given-names></name>
<name><surname>Houser</surname><given-names>S.R.</given-names></name>
<name><surname>Wallner</surname><given-names>M.</given-names></name>
</person-group><article-title>Diabetic cardiomyopathy: Current and future therapies. Beyond glycemic control</article-title><source>Front. Physiol.</source><year>2018</year><volume>9</volume><elocation-id>1514</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.01514</pub-id><pub-id pub-id-type="pmid">30425649</pub-id>
</element-citation></ref><ref id="B91-jdb-13-00017"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>E.I.</given-names></name>
<name><surname>Stremming</surname><given-names>J.</given-names></name>
<name><surname>Knaub</surname><given-names>L.A.</given-names></name>
<name><surname>Wesolowski</surname><given-names>S.R.</given-names></name>
<name><surname>Rozance</surname><given-names>P.J.</given-names></name>
<name><surname>Sucharov</surname><given-names>C.C.</given-names></name>
<name><surname>Reusch</surname><given-names>J.E.B.</given-names></name>
<name><surname>Brown</surname><given-names>L.D.</given-names></name>
</person-group><article-title>Mitochondrial respiration is lower in the intrauterine growth-restricted fetal sheep heart</article-title><source>J. Physiol.</source><year>2024</year><volume>602</volume><fpage>2697</fpage><lpage>2715</lpage><pub-id pub-id-type="doi">10.1113/JP285496</pub-id><pub-id pub-id-type="pmid">38743350</pub-id>
</element-citation></ref><ref id="B92-jdb-13-00017"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fassone</surname><given-names>E.</given-names></name>
<name><surname>Rahman</surname><given-names>S.</given-names></name>
</person-group><article-title>Complex I deficiency: Clinical features, biochemistry and molecular genetics</article-title><source>J. Med. Genet.</source><year>2012</year><volume>49</volume><fpage>578</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101159</pub-id><pub-id pub-id-type="pmid">22972949</pub-id>
</element-citation></ref><ref id="B93-jdb-13-00017"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rowles</surname><given-names>J.</given-names></name>
<name><surname>Scherer</surname><given-names>S.W.</given-names></name>
<name><surname>Xi</surname><given-names>T.</given-names></name>
<name><surname>Majer</surname><given-names>M.</given-names></name>
<name><surname>Nickle</surname><given-names>D.C.</given-names></name>
<name><surname>Rommens</surname><given-names>J.M.</given-names></name>
<name><surname>Popov</surname><given-names>K.M.</given-names></name>
<name><surname>Harris</surname><given-names>R.A.</given-names></name>
<name><surname>Riebow</surname><given-names>N.L.</given-names></name>
<name><surname>Xia</surname><given-names>J.</given-names></name>
</person-group><article-title>Cloning and characterization of PDK4 on 7q21. 3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human</article-title><source>J. Biol. Chem.</source><year>1996</year><volume>271</volume><fpage>22376</fpage><lpage>22382</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.37.22376</pub-id><pub-id pub-id-type="pmid">8798399</pub-id>
</element-citation></ref><ref id="B94-jdb-13-00017"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sugden</surname><given-names>M.C.</given-names></name>
<name><surname>Holness</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs</article-title><source>Am. J. Physiol.-Endocrinol. Metab.</source><year>2003</year><volume>284</volume><fpage>E855</fpage><lpage>E862</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00526.2002</pub-id><pub-id pub-id-type="pmid">12676647</pub-id>
</element-citation></ref><ref id="B95-jdb-13-00017"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bowker-Kinley</surname><given-names>M.M.</given-names></name>
<name><surname>Davis</surname><given-names>I.W.</given-names></name>
<name><surname>Wu</surname><given-names>P.</given-names></name>
<name><surname>Harris</surname><given-names>A.R.</given-names></name>
<name><surname>Popov</surname><given-names>M.K.</given-names></name>
</person-group><article-title>Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex</article-title><source>Biochem. J.</source><year>1998</year><volume>329</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1042/bj3290191</pub-id><pub-id pub-id-type="pmid">9405293</pub-id>
</element-citation></ref><ref id="B96-jdb-13-00017"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>D.H.</given-names></name>
<name><surname>Chauhan</surname><given-names>S.</given-names></name>
</person-group><article-title>The role of dichloroacetate in improving acute hypoxic tolerance and cardiac function: Translation to failing hearts?</article-title><source>J. Physiol.</source><year>2018</year><volume>596</volume><fpage>2967</fpage><pub-id pub-id-type="doi">10.1113/JP276217</pub-id><pub-id pub-id-type="pmid">29781527</pub-id>
</element-citation></ref><ref id="B97-jdb-13-00017"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harris</surname><given-names>R.A.</given-names></name>
<name><surname>Bowker-Kinley</surname><given-names>M.M.</given-names></name>
<name><surname>Huang</surname><given-names>B.</given-names></name>
<name><surname>Wu</surname><given-names>P.</given-names></name>
</person-group><article-title>Regulation of the activity of the pyruvate dehydrogenase complex</article-title><source>Adv. Enzym. Regul.</source><year>2002</year><volume>42</volume><fpage>249</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/S0065-2571(01)00061-9</pub-id><pub-id pub-id-type="pmid">12123719</pub-id>
</element-citation></ref><ref id="B98-jdb-13-00017"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sheeran</surname><given-names>F.L.</given-names></name>
<name><surname>Angerosa</surname><given-names>J.</given-names></name>
<name><surname>Liaw</surname><given-names>N.Y.</given-names></name>
<name><surname>Cheung</surname><given-names>M.M.</given-names></name>
<name><surname>Pepe</surname><given-names>S.</given-names></name>
</person-group><article-title>Adaptations in Protein Expression and Regulated Activity of Pyruvate Dehydrogenase Multienzyme Complex in Human Systolic Heart Failure</article-title><source>Oxidative Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><fpage>4532592</fpage><pub-id pub-id-type="doi">10.1155/2019/4532592</pub-id><pub-id pub-id-type="pmid">30881593</pub-id>
</element-citation></ref><ref id="B99-jdb-13-00017"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karwi</surname><given-names>Q.G.</given-names></name>
<name><surname>Uddin</surname><given-names>G.M.</given-names></name>
<name><surname>Ho</surname><given-names>K.L.</given-names></name>
<name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Loss of Metabolic Flexibility in the Failing Heart</article-title><source>Front. Cardiovasc. Med.</source><year>2018</year><volume>5</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2018.00068</pub-id><pub-id pub-id-type="pmid">29928647</pub-id>
</element-citation></ref><ref id="B100-jdb-13-00017"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name>
<name><surname>Ussher</surname><given-names>J.R.</given-names></name>
<name><surname>Folmes</surname><given-names>C.D.</given-names></name>
<name><surname>Jaswal</surname><given-names>J.S.</given-names></name>
<name><surname>Stanley</surname><given-names>W.C.</given-names></name>
</person-group><article-title>Myocardial fatty acid metabolism in health and disease</article-title><source>Physiol. Rev.</source><year>2010</year><volume>90</volume><fpage>207</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1152/physrev.00015.2009</pub-id><pub-id pub-id-type="pmid">20086077</pub-id>
</element-citation></ref><ref id="B101-jdb-13-00017"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhabyeyev</surname><given-names>P.</given-names></name>
<name><surname>Gandhi</surname><given-names>M.</given-names></name>
<name><surname>Mori</surname><given-names>J.</given-names></name>
<name><surname>Basu</surname><given-names>R.</given-names></name>
<name><surname>Kassiri</surname><given-names>Z.</given-names></name>
<name><surname>Clanachan</surname><given-names>A.</given-names></name>
<name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name>
<name><surname>Oudit</surname><given-names>G.Y.</given-names></name>
</person-group><article-title>Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload</article-title><source>Cardiovasc. Res.</source><year>2013</year><volume>97</volume><fpage>676</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvs424</pub-id><pub-id pub-id-type="pmid">23257023</pub-id>
</element-citation></ref><ref id="B102-jdb-13-00017"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Jaswal</surname><given-names>J.S.</given-names></name>
<name><surname>Ussher</surname><given-names>J.R.</given-names></name>
<name><surname>Sankaralingam</surname><given-names>S.</given-names></name>
<name><surname>Wagg</surname><given-names>C.</given-names></name>
<name><surname>Zaugg</surname><given-names>M.</given-names></name>
<name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy</article-title><source>Circ. Heart Fail.</source><year>2013</year><volume>6</volume><fpage>1039</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.112.000228</pub-id><pub-id pub-id-type="pmid">23861485</pub-id>
</element-citation></ref><ref id="B103-jdb-13-00017"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Birben</surname><given-names>E.</given-names></name>
<name><surname>Sahiner</surname><given-names>U.M.</given-names></name>
<name><surname>Sackesen</surname><given-names>C.</given-names></name>
<name><surname>Erzurum</surname><given-names>S.</given-names></name>
<name><surname>Kalayci</surname><given-names>O.</given-names></name>
</person-group><article-title>Oxidative stress and antioxidant defense</article-title><source>World Allergy Organ. J.</source><year>2012</year><volume>5</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1097/WOX.0b013e3182439613</pub-id><pub-id pub-id-type="pmid">23268465</pub-id>
</element-citation></ref><ref id="B104-jdb-13-00017"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lijnen</surname><given-names>P.J.</given-names></name>
<name><surname>van Pelt</surname><given-names>J.F.</given-names></name>
<name><surname>Fagard</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Downregulation of Manganese Superoxide Dismutase by Angiotensin II in Cardiac Fibroblasts of Rats: Association With Oxidative Stress in Myocardium</article-title><source>Am. J. Hypertens.</source><year>2010</year><volume>23</volume><fpage>1128</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1038/ajh.2010.128</pub-id><pub-id pub-id-type="pmid">20596034</pub-id>
</element-citation></ref><ref id="B105-jdb-13-00017"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>K.</given-names></name>
<name><surname>Murtuza</surname><given-names>B.</given-names></name>
<name><surname>Sammut</surname><given-names>I.A.</given-names></name>
<name><surname>Latif</surname><given-names>N.</given-names></name>
<name><surname>Jayakumar</surname><given-names>J.</given-names></name>
<name><surname>Smolenski</surname><given-names>R.T.</given-names></name>
<name><surname>Kaneda</surname><given-names>Y.</given-names></name>
<name><surname>Sawa</surname><given-names>Y.</given-names></name>
<name><surname>Matsuda</surname><given-names>H.</given-names></name>
<name><surname>Yacoub</surname><given-names>M.H.</given-names></name>
</person-group><article-title>Heat Shock Protein 72 Enhances Manganese Superoxide Dismutase Activity During Myocardial Ischemia-Reperfusion Injury, Associated With Mitochondrial Protection and Apoptosis Reduction</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>I-270</fpage><lpage>I-276</lpage><pub-id pub-id-type="doi">10.1161/01.cir.0000032880.55215.92</pub-id><pub-id pub-id-type="pmid">12354745</pub-id>
</element-citation></ref><ref id="B106-jdb-13-00017"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nojiri</surname><given-names>H.</given-names></name>
<name><surname>Shimizu</surname><given-names>T.</given-names></name>
<name><surname>Funakoshi</surname><given-names>M.</given-names></name>
<name><surname>Yamaguchi</surname><given-names>O.</given-names></name>
<name><surname>Zhou</surname><given-names>H.</given-names></name>
<name><surname>Kawakami</surname><given-names>S.</given-names></name>
<name><surname>Ohta</surname><given-names>Y.</given-names></name>
<name><surname>Sami</surname><given-names>M.</given-names></name>
<name><surname>Tachibana</surname><given-names>T.</given-names></name>
<name><surname>Ishikawa</surname><given-names>H.</given-names></name>
</person-group><article-title>Oxidative stress causes heart failure with impaired mitochondrial respiration</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>33789</fpage><lpage>33801</lpage><pub-id pub-id-type="doi">10.1074/jbc.M602118200</pub-id><pub-id pub-id-type="pmid">16959785</pub-id>
</element-citation></ref><ref id="B107-jdb-13-00017"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsushima</surname><given-names>S.</given-names></name>
<name><surname>Ide</surname><given-names>T.</given-names></name>
<name><surname>Yamato</surname><given-names>M.</given-names></name>
<name><surname>Matsusaka</surname><given-names>H.</given-names></name>
<name><surname>Hattori</surname><given-names>F.</given-names></name>
<name><surname>Ikeuchi</surname><given-names>M.</given-names></name>
<name><surname>Kubota</surname><given-names>T.</given-names></name>
<name><surname>Sunagawa</surname><given-names>K.</given-names></name>
<name><surname>Hasegawa</surname><given-names>Y.</given-names></name>
<name><surname>Kurihara</surname><given-names>T.</given-names></name>
</person-group><article-title>Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>1779</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.582239</pub-id><pub-id pub-id-type="pmid">16585391</pub-id>
</element-citation></ref><ref id="B108-jdb-13-00017"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sam</surname><given-names>F.</given-names></name>
<name><surname>Kerstetter</surname><given-names>D.L.</given-names></name>
<name><surname>Pimental</surname><given-names>D.R.</given-names></name>
<name><surname>Mulukutla</surname><given-names>S.</given-names></name>
<name><surname>Tabaee</surname><given-names>A.</given-names></name>
<name><surname>Bristow</surname><given-names>M.R.</given-names></name>
<name><surname>Colucci</surname><given-names>W.S.</given-names></name>
<name><surname>Sawyer</surname><given-names>D.B.</given-names></name>
</person-group><article-title>Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium</article-title><source>J. Card. Fail.</source><year>2005</year><volume>11</volume><fpage>473</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.cardfail.2005.01.007</pub-id><pub-id pub-id-type="pmid">16105639</pub-id>
</element-citation></ref><ref id="B109-jdb-13-00017"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsai-Turton</surname><given-names>M.</given-names></name>
<name><surname>Luderer</surname><given-names>U.</given-names></name>
</person-group><article-title>Opposing effects of glutathione depletion and follicle-stimulating hormone on reactive oxygen species and apoptosis in cultured preovulatory rat follicles</article-title><source>Endocrinology</source><year>2006</year><volume>147</volume><fpage>1224</fpage><lpage>1236</lpage><pub-id pub-id-type="doi">10.1210/en.2005-1281</pub-id><pub-id pub-id-type="pmid">16339198</pub-id>
</element-citation></ref><ref id="B110-jdb-13-00017"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almansa-Ordonez</surname><given-names>A.</given-names></name>
<name><surname>Bellido</surname><given-names>R.</given-names></name>
<name><surname>Vassena</surname><given-names>R.</given-names></name>
<name><surname>Barragan</surname><given-names>M.</given-names></name>
<name><surname>Zambelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Oxidative Stress in Reproduction: A Mitochondrial Perspective</article-title><source>Biology</source><year>2020</year><volume>9</volume><elocation-id>269</elocation-id><pub-id pub-id-type="doi">10.3390/biology9090269</pub-id><pub-id pub-id-type="pmid">32899860</pub-id>
</element-citation></ref><ref id="B111-jdb-13-00017"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miyamoto</surname><given-names>K.</given-names></name>
<name><surname>Sato</surname><given-names>E.F.</given-names></name>
<name><surname>Kasahara</surname><given-names>E.</given-names></name>
<name><surname>Jikumaru</surname><given-names>M.</given-names></name>
<name><surname>Hiramoto</surname><given-names>K.</given-names></name>
<name><surname>Tabata</surname><given-names>H.</given-names></name>
<name><surname>Katsuragi</surname><given-names>M.</given-names></name>
<name><surname>Odo</surname><given-names>S.</given-names></name>
<name><surname>Utsumi</surname><given-names>K.</given-names></name>
<name><surname>Inoue</surname><given-names>M.</given-names></name>
</person-group><article-title>Effect of oxidative stress during repeated ovulation on the structure and functions of the ovary, oocytes, and their mitochondria</article-title><source>Free Radic. Biol. Med.</source><year>2010</year><volume>49</volume><fpage>674</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.05.025</pub-id><pub-id pub-id-type="pmid">20621580</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="jdb-13-00017-f001"><label>Figure 1</label><caption><p>IVC did not impact cardiac hormones and glucocorticoid receptors. Males (M) = circles; females (F) = triangles. NM&#x02014;natural mate (hormone = 5M, 3F; protein = 5M, 4F). ET&#x02014;embryo transfer (hormone = 5M, 5F; protein = 5M, 5F). IVC&#x02014;<italic toggle="yes">in vitro</italic> embryo culture (hormone = 5M, 6F; protein = 5M, 6F). IVCHS&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum (hormone = 4M, 5F; protein = 4M, 5F). IVCHS+M&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum and methionine supplementation (hormone = 5M, 4F; protein = 5M, 4F). (<bold>A</bold>) Cortisol, (<bold>B</bold>) Cortisone, (<bold>C</bold>) Cortisol: Cortisone, (<bold>D</bold>) Corticosterone, (<bold>E</bold>) Testosterone, (<bold>F</bold>) T<sub>3</sub>, (<bold>G</bold>) T<sub>4</sub>, (<bold>H</bold>) T<sub>3</sub>: T<sub>4</sub>, (<bold>I</bold>) GR&#x003b1;-A, (<bold>J</bold>) GR&#x003b1;-C, (<bold>K</bold>) GR&#x003b1;-D3. Hormone concentrations were measured using LC-MS/MS, and protein expression was assessed via Western blot. One outlier was excluded from each group, when applicable, using the Dixon Q test (&#x003b1; = 0.05). Data are presented as mean &#x000b1; SD and analyzed using two-way ANOVA, followed by Tukey&#x02019;s multiple comparisons test. Means with different superscript letters are significantly different (<italic toggle="yes">p</italic> &#x0003c; 0.05). (*) indicates mean values that are significantly different within the same group (<italic toggle="yes">p</italic> &#x0003c; 0.05). AU: arbitrary unit. (X) indicates data excluded from analysis (due to an artifact on the band/s).</p></caption><graphic xlink:href="jdb-13-00017-g001" position="float"/></fig><fig position="float" id="jdb-13-00017-f002"><label>Figure 2</label><caption><p>IVC reduced mitochondrial abundance and OXPHOS, particularly in males. Males (M) = circles; females (F) = triangles. NM&#x02014;natural mate (protein = 5M, 4F). ET&#x02014;embryo transfer (protein = 5M, 5F). IVC&#x02014;<italic toggle="yes">in vitro</italic> embryo culture (protein = 5M, 6F). IVCHS&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum (protein = 4M, 5F). IVCHS+M&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum and methionine supplementation (protein = 5M, 4F). (<bold>A</bold>) Complex 1, (<bold>B</bold>) Complex 2, (<bold>C</bold>) Complex 3, (<bold>D</bold>) Complex 4, (<bold>E</bold>) Complex 5, (<bold>F</bold>) Mitochondrial content (MT-COXI: SDHA). Protein expression was assessed via Western blot. One outlier was excluded from each group, when applicable, using the Dixon Q test (&#x003b1; = 0.05). Data are presented as mean &#x000b1; SD and analyzed using two-way ANOVA, followed by Tukey&#x02019;s multiple comparisons test. Means with different superscript letters are significantly different (<italic toggle="yes">p</italic> &#x0003c; 0.05). (*) indicates mean values that are significantly different within the same group (<italic toggle="yes">p</italic> &#x0003c; 0.05). AU: arbitrary unit. (X) indicates data excluded from analysis (due to an artifact on the band/s).</p></caption><graphic xlink:href="jdb-13-00017-g002" position="float"/></fig><fig position="float" id="jdb-13-00017-f003"><label>Figure 3</label><caption><p>IVC altered a marker of cardiac metabolic switch. Males (M) = circles; females (F) = triangles. NM&#x02014;natural mate (protein = 5M, 4F; mRNA = 5M, 4F). ET&#x02014;embryo transfer (protein = 5M, 5F, mRNA = 5M, 5F). IVC&#x02014;<italic toggle="yes">in vitro</italic> embryo culture (protein = 5M, 6F; mRNA = 5M, 6F). IVCHS&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum (protein = 4M, 5F; mRNA = 4M, 5F). IVCHS+M&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum and methionine supplementation (protein = 5M, 4F; mRNA = 5M, 4F). (<bold>A</bold>) p-IRS1: IRS-1, (<bold>B</bold>) p-AS160: AS160, (<bold>C</bold>) GLUT4 (gene), (<bold>D</bold>) GLUT4, (<bold>E</bold>) GSK3&#x003b2; (gene), (<bold>F</bold>) PDK-4. Protein expression was assessed via Western blot, and gene expression was analyzed using real-time RT-PCR. One outlier was excluded from each group, when applicable, using the Dixon Q test (&#x003b1; = 0.05). Data are presented as mean &#x000b1; SD and analyzed using two-way ANOVA, followed by Tukey&#x02019;s multiple comparisons test. Means with different superscript letters are significantly different (<italic toggle="yes">p</italic> &#x0003c; 0.05). (*) indicates mean values that are significantly different within the same group (<italic toggle="yes">p</italic> &#x0003c; 0.05). AU: arbitrary unit. (X) indicates data excluded from analysis (due to an artifact on the band/s).</p></caption><graphic xlink:href="jdb-13-00017-g003" position="float"/></fig><fig position="float" id="jdb-13-00017-f004"><label>Figure 4</label><caption><p>IVC did not alter markers of cardiac fatty acid metabolism. Males (M) = circles; females (F) = triangles. NM&#x02014;natural mate (protein = 5M, 4F; mRNA = 5M, 4F). ET&#x02014;embryo transfer (protein = 5M, 5F; mRNA = 5M, 5F). IVC&#x02014;<italic toggle="yes">in vitro</italic> embryo culture (protein = 5M, 6F; mRNA = 5M, 6F). IVCHS&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum (protein = 4M, 5F; mRNA = 4M, 5F). IVCHS+M&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum and methionine supplementation (protein = 5M, 4F; mRNA = 5M, 4F). (<bold>A</bold>) CD36 (gene), (<bold>B</bold>) CD36, (<bold>C</bold>) CPTI (gene), (<bold>D</bold>) CPTI, (<bold>E</bold>) PPAR&#x003b1; (gene), (<bold>F</bold>) PPAR&#x003b3; (gene), (<bold>G</bold>) ACC (gene), (<bold>H</bold>) PC (gene). Protein expression was assessed via Western blot, and gene expression was analyzed using real-time RT-PCR. One outlier was excluded from each group, when applicable, using the Dixon Q test (&#x003b1; = 0.05). Data are presented as mean &#x000b1; SD and analyzed using two-way ANOVA, followed by Tukey&#x02019;s multiple comparisons test. Means with different superscript letters are significantly different (<italic toggle="yes">p</italic> &#x0003c; 0.05). (*) indicates mean values that are significantly different within the same group (<italic toggle="yes">p</italic> &#x0003c; 0.05). AU: arbitrary unit. (X) indicates data excluded from analysis (due to an artifact on the band/s).</p></caption><graphic xlink:href="jdb-13-00017-g004" position="float"/></fig><fig position="float" id="jdb-13-00017-f005"><label>Figure 5</label><caption><p>IVC reduced a marker of cardiac antioxidant defense, with no effect on contractility markers. Males (M) = circles; females (F) = triangles. NM&#x02014;natural mate (protein = 5M, 4F; mRNA = 5M, 4F). ET&#x02014;embryo transfer (protein = 5M, 5F; mRNA = 5M, 5F). IVC&#x02014;<italic toggle="yes">in vitro</italic> embryo culture (protein = 5M, 6F; mRNA = 5M, 6F). IVCHS&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum (protein = 4M, 5F; mRNA = 4M, 5F). IVCHS+M&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum and methionine supplementation (protein = 5M, 4F; mRNA = 5M, 4F). (<bold>A</bold>) p-CAMKII: CAMKII, (<bold>B</bold>) p-PLN: PLN, (<bold>C</bold>) SERCA2, (<bold>D</bold>) p-TroponinI: TroponinI, (<bold>E</bold>) PGC1&#x003b1; (gene), (<bold>F</bold>) PGC1&#x003b1;, (<bold>G</bold>) Mn-SOD, (<bold>H</bold>) NOX-2. Protein expression was assessed via Western blot, and gene expression was analyzed using real-time RT-PCR. One outlier was excluded from each group, when applicable, using the Dixon Q test (&#x003b1; = 0.05). Data are presented as mean &#x000b1; SD and analyzed using two-way ANOVA, followed by Tukey&#x02019;s multiple comparisons test. Means with different superscript letters are significantly different (<italic toggle="yes">p</italic> &#x0003c; 0.05). (*) indicates mean values that are significantly different within the same group (<italic toggle="yes">p</italic> &#x0003c; 0.05). AU: arbitrary unit.</p></caption><graphic xlink:href="jdb-13-00017-g005" position="float"/></fig><fig position="float" id="jdb-13-00017-f006"><label>Figure 6</label><caption><p>IVC did not alter cardiac glycogen and collagen staining. Representative micrograph (20&#x000d7; magnification) of glycogen staining using PAS (black arrow) in NM (<bold>A</bold>), ET (<bold>B</bold>), IVC (<bold>C</bold>), IVCHS (<bold>D</bold>), and IVCHS+M (<bold>E</bold>) groups. Representative micrograph (20&#x000d7; magnification) of collagen staining using Masson&#x02019;s trichrome (black arrow) in NM (<bold>F</bold>), ET (<bold>G</bold>), IVC (<bold>H</bold>), IVCHS (<bold>I</bold>), IVCHS+M (<bold>J</bold>) groups. Glycogen (<bold>K</bold>) and collagen (<bold>L</bold>) content in the cardiac. Males (M) = circles; females (F) = triangles. NM&#x02014;natural mate (histology = 5M, 4F). ET&#x02014;embryo transfer (histology = 5M, 5F). IVC&#x02014;<italic toggle="yes">in vitro</italic> embryo culture (histology = 5M, 6F). IVCHS&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum (histology = 4M, 5F). IVCHS+M&#x02014;<italic toggle="yes">in vitro</italic> embryo culture with human serum and methionine supplementation (histology = 5M, 3F). One outlier was excluded from each group, when applicable, using the Dixon Q test (&#x003b1; = 0.05). Data are presented as mean &#x000b1; SD and analyzed using two-way ANOVA, followed by Tukey&#x02019;s multiple comparisons test. </p></caption><graphic xlink:href="jdb-13-00017-g006" position="float"/></fig></floats-group></article>